| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | voltage-gated sodium channel activity | 1.11e-11 | 26 | 149 | 8 | GO:0005248 | |
| GeneOntologyMolecularFunction | sodium channel activity | 4.54e-09 | 52 | 149 | 8 | GO:0005272 | |
| GeneOntologyMolecularFunction | alkali metal ion binding | 3.18e-08 | 26 | 149 | 6 | GO:0031420 | |
| GeneOntologyMolecularFunction | sodium ion binding | 4.10e-08 | 14 | 149 | 5 | GO:0031402 | |
| GeneOntologyMolecularFunction | ABC-type xenobiotic transporter activity | 3.81e-06 | 15 | 149 | 4 | GO:0008559 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | KRAS ABCC3 ABCC4 NRAS ABCB5 RNF213 CCT4 ACYP1 GTPBP10 NLRP3 ABCB1 ARFRP1 SEPTIN3 RAB4B ABCB10 MTIF2 HRAS HFM1 DDX43 HSPA2 | 4.42e-06 | 839 | 149 | 20 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | KRAS ABCC3 ABCC4 NRAS ABCB5 RNF213 CCT4 ACYP1 GTPBP10 NLRP3 ABCB1 ARFRP1 SEPTIN3 RAB4B ABCB10 MTIF2 HRAS HFM1 DDX43 HSPA2 | 4.50e-06 | 840 | 149 | 20 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | KRAS ABCC3 ABCC4 NRAS ABCB5 RNF213 CCT4 ACYP1 GTPBP10 NLRP3 ABCB1 ARFRP1 SEPTIN3 RAB4B ABCB10 MTIF2 HRAS HFM1 DDX43 HSPA2 | 4.50e-06 | 840 | 149 | 20 | GO:0016818 |
| GeneOntologyMolecularFunction | xenobiotic transmembrane transporter activity | 5.05e-06 | 34 | 149 | 5 | GO:0042910 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | KRAS ABCC3 ABCC4 NRAS ABCB5 RNF213 CCT4 GTPBP10 NLRP3 ABCB1 ARFRP1 SEPTIN3 RAB4B ABCB10 MTIF2 HRAS HFM1 DDX43 HSPA2 | 5.26e-06 | 775 | 149 | 19 | GO:0017111 |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 5.61e-06 | 171 | 149 | 9 | GO:0015081 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | ABCC3 ABCC4 SLC37A3 KCNV2 ABCB5 PKD1L2 RYR3 ABCB1 MFSD14A NDUFA12 ABCB10 SLC50A1 SCN1A SLC7A5P2 SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A SCN10A SLC5A8 SLC26A11 ANO3 | 6.91e-06 | 1180 | 149 | 24 | GO:0022857 |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | ABCC3 ABCC4 SLC37A3 KCNV2 PKD1L2 RYR3 NDUFA12 SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A SCN10A SLC5A8 SLC26A11 ANO3 | 1.46e-05 | 758 | 149 | 18 | GO:0015318 |
| GeneOntologyMolecularFunction | transporter activity | ABCC3 ABCC4 SLC37A3 KCNV2 ABCB5 PKD1L2 RYR3 ABCB1 MFSD14A NDUFA12 ABCB10 SLC50A1 SCN1A SLC7A5P2 SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A SCN10A SLC5A8 SLC26A11 ANO3 | 2.96e-05 | 1289 | 149 | 24 | GO:0005215 |
| GeneOntologyMolecularFunction | ABC-type transporter activity | 3.17e-05 | 49 | 149 | 5 | GO:0140359 | |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | KCNV2 PKD1L2 RYR3 SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A SCN10A SLC5A8 SLC26A11 ANO3 | 4.10e-05 | 526 | 149 | 14 | GO:0022803 |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | KCNV2 PKD1L2 RYR3 SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A SCN10A SLC26A11 ANO3 | 4.14e-05 | 459 | 149 | 13 | GO:0005216 |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | 4.73e-05 | 127 | 149 | 7 | GO:0016616 | |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | KCNV2 PKD1L2 RYR3 SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A SCN10A | 5.48e-05 | 343 | 149 | 11 | GO:0005261 |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on CH-OH group of donors | 8.02e-05 | 138 | 149 | 7 | GO:0016614 | |
| GeneOntologyMolecularFunction | channel activity | KCNV2 PKD1L2 RYR3 SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A SCN10A SLC26A11 ANO3 | 1.60e-04 | 525 | 149 | 13 | GO:0015267 |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | KCNV2 PKD1L2 RYR3 SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A SCN10A SLC5A8 | 1.97e-04 | 465 | 149 | 12 | GO:0046873 |
| GeneOntologyMolecularFunction | efflux transmembrane transporter activity | 2.12e-04 | 16 | 149 | 3 | GO:0015562 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential | 2.56e-04 | 17 | 149 | 3 | GO:0099508 | |
| GeneOntologyMolecularFunction | ABC-type bile acid transporter activity | 3.29e-04 | 4 | 149 | 2 | GO:0015432 | |
| GeneOntologyMolecularFunction | ATPase-coupled organic acid transmembrane transporter activity | 3.29e-04 | 4 | 149 | 2 | GO:0033283 | |
| GeneOntologyMolecularFunction | ATPase-coupled monocarboxylic acid transmembrane transporter activity | 3.29e-04 | 4 | 149 | 2 | GO:0033285 | |
| GeneOntologyMolecularFunction | ATPase-coupled carboxylic acid transmembrane transporter activity | 3.29e-04 | 4 | 149 | 2 | GO:0033284 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | ABCC3 ABCC4 ABCB5 RNF213 CCT4 NLRP3 ABCB1 ABCB10 HFM1 DDX43 HSPA2 | 4.85e-04 | 441 | 149 | 11 | GO:0016887 |
| GeneOntologyMolecularFunction | NADH binding | 5.45e-04 | 5 | 149 | 2 | GO:0070404 | |
| GeneOntologyMolecularFunction | voltage-gated sodium channel activity involved in cardiac muscle cell action potential | 8.13e-04 | 6 | 149 | 2 | GO:0086006 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | KCNV2 PKD1L2 RYR3 NDUFA12 SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A SCN10A SLC5A8 | 8.59e-04 | 627 | 149 | 13 | GO:0022890 |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | KCNV2 PKD1L2 RYR3 NDUFA12 SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A SCN10A SLC5A8 SLC26A11 ANO3 | 8.83e-04 | 793 | 149 | 15 | GO:0015075 |
| GeneOntologyMolecularFunction | G protein activity | 9.85e-04 | 59 | 149 | 4 | GO:0003925 | |
| GeneOntologyMolecularFunction | ADP-D-ribose modification-dependent protein binding | 1.13e-03 | 7 | 149 | 2 | GO:0160002 | |
| GeneOntologyMolecularFunction | ATPase-coupled transmembrane transporter activity | 1.36e-03 | 109 | 149 | 5 | GO:0042626 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | KCNV2 PKD1L2 RYR3 NDUFA12 SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A SCN10A SLC5A8 | 1.44e-03 | 664 | 149 | 13 | GO:0008324 |
| GeneOntologyMolecularFunction | ABC-type glutathione S-conjugate transporter activity | 1.50e-03 | 8 | 149 | 2 | GO:0015431 | |
| GeneOntologyMolecularFunction | phospholipase D activity | 1.50e-03 | 8 | 149 | 2 | GO:0004630 | |
| GeneOntologyMolecularFunction | calmodulin binding | 1.73e-03 | 230 | 149 | 7 | GO:0005516 | |
| GeneOntologyMolecularFunction | ATPase-coupled lipid transmembrane transporter activity | 1.92e-03 | 9 | 149 | 2 | GO:0034040 | |
| GeneOntologyMolecularFunction | primary active transmembrane transporter activity | 2.21e-03 | 178 | 149 | 6 | GO:0015399 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | ABCC3 ABCC4 CENPE ABCB5 RNF213 CCT4 NLRP3 ABCB1 ABCB10 HFM1 DDX43 HSPA2 | 2.22e-03 | 614 | 149 | 12 | GO:0140657 |
| GeneOntologyMolecularFunction | mitogen-activated protein kinase binding | 2.24e-03 | 35 | 149 | 3 | GO:0051019 | |
| GeneOntologyMolecularFunction | ATPase-coupled inorganic anion transmembrane transporter activity | 2.39e-03 | 10 | 149 | 2 | GO:0043225 | |
| GeneOntologyMolecularFunction | NF-kappaB binding | 2.43e-03 | 36 | 149 | 3 | GO:0051059 | |
| GeneOntologyBiologicalProcess | membrane depolarization during action potential | 1.40e-10 | 36 | 147 | 8 | GO:0086010 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell action potential | 1.19e-08 | 87 | 147 | 9 | GO:0086001 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell action potential involved in contraction | 1.34e-08 | 62 | 147 | 8 | GO:0086002 | |
| GeneOntologyBiologicalProcess | neuronal action potential | 1.53e-08 | 63 | 147 | 8 | GO:0019228 | |
| GeneOntologyBiologicalProcess | striated muscle contraction | VPS54 RYR3 SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A SCN10A DMD GAA | 5.23e-08 | 217 | 147 | 12 | GO:0006941 |
| GeneOntologyBiologicalProcess | membrane depolarization | 2.13e-07 | 121 | 147 | 9 | GO:0051899 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell contraction | 3.36e-07 | 93 | 147 | 8 | GO:0086003 | |
| GeneOntologyBiologicalProcess | cardiac muscle contraction | 3.38e-07 | 167 | 147 | 10 | GO:0060048 | |
| GeneOntologyBiologicalProcess | detection of mechanical stimulus | 1.07e-06 | 75 | 147 | 7 | GO:0050982 | |
| GeneOntologyBiologicalProcess | transmission of nerve impulse | 1.40e-06 | 112 | 147 | 8 | GO:0019226 | |
| GeneOntologyBiologicalProcess | action potential | 1.84e-06 | 201 | 147 | 10 | GO:0001508 | |
| GeneOntologyBiologicalProcess | actin-mediated cell contraction | 3.60e-06 | 127 | 147 | 8 | GO:0070252 | |
| GeneOntologyBiologicalProcess | circulatory system process | ABCC3 ABCC4 DDAH1 ABL1 ARHGEF12 ABCB1 POSTN THRB SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A SCN10A DMD GAA | 4.94e-06 | 733 | 147 | 18 | GO:0003013 |
| GeneOntologyBiologicalProcess | heart contraction | THRB SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A SCN10A DMD GAA | 9.88e-06 | 298 | 147 | 11 | GO:0060047 |
| GeneOntologyBiologicalProcess | heart process | THRB SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A SCN10A DMD GAA | 1.39e-05 | 309 | 147 | 11 | GO:0003015 |
| GeneOntologyBiologicalProcess | actin filament-based movement | 1.42e-05 | 153 | 147 | 8 | GO:0030048 | |
| GeneOntologyBiologicalProcess | sodium ion transmembrane transport | 1.88e-05 | 208 | 147 | 9 | GO:0035725 | |
| GeneOntologyBiologicalProcess | sodium ion transport | 2.88e-05 | 275 | 147 | 10 | GO:0006814 | |
| GeneOntologyBiologicalProcess | muscle contraction | VPS54 RYR3 SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A SCN10A DMD GAA | 3.06e-05 | 400 | 147 | 12 | GO:0006936 |
| GeneOntologyBiologicalProcess | detection of mechanical stimulus involved in sensory perception | 5.34e-05 | 57 | 147 | 5 | GO:0050974 | |
| GeneOntologyBiologicalProcess | blood circulation | DDAH1 ABL1 ARHGEF12 POSTN THRB SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A SCN10A DMD GAA | 6.25e-05 | 648 | 147 | 15 | GO:0008015 |
| GeneOntologyBiologicalProcess | response to mechanical stimulus | 7.18e-05 | 247 | 147 | 9 | GO:0009612 | |
| GeneOntologyBiologicalProcess | xenobiotic transport | 9.34e-05 | 64 | 147 | 5 | GO:0042908 | |
| GeneOntologyBiologicalProcess | UDP-N-acetylglucosamine metabolic process | 1.22e-04 | 14 | 147 | 3 | GO:0006047 | |
| GeneOntologyBiologicalProcess | musculoskeletal movement | 1.34e-04 | 69 | 147 | 5 | GO:0050881 | |
| GeneOntologyBiologicalProcess | muscle system process | VPS54 RYR3 SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A SCN10A DMD EP300 GAA | 1.52e-04 | 547 | 147 | 13 | GO:0003012 |
| GeneOntologyBiologicalProcess | multicellular organismal movement | 1.75e-04 | 73 | 147 | 5 | GO:0050879 | |
| GeneOntologyBiologicalProcess | neuromuscular process | 2.15e-04 | 225 | 147 | 8 | GO:0050905 | |
| GeneOntologyBiologicalProcess | detection of external stimulus | 2.46e-04 | 173 | 147 | 7 | GO:0009581 | |
| GeneOntologyBiologicalProcess | response to abiotic stimulus | KRAS GPLD1 DDAH1 MAPKAPK2 PDZD7 RDH13 ADGRV1 XRCC1 PKD1L2 NLRP3 ABCB1 POSTN SCN1A SCN2A SCN9A SCN10A HRAS PKLR DMD HSPA2 ANO3 EP300 | 2.58e-04 | 1361 | 147 | 22 | GO:0009628 |
| GeneOntologyBiologicalProcess | detection of abiotic stimulus | 2.64e-04 | 175 | 147 | 7 | GO:0009582 | |
| GeneOntologyBiologicalProcess | nucleotide-sugar metabolic process | 2.69e-04 | 44 | 147 | 4 | GO:0009225 | |
| GeneOntologyBiologicalProcess | negative regulation of transcription of nucleolar large rRNA by RNA polymerase I | 3.00e-04 | 4 | 147 | 2 | GO:1901837 | |
| GeneOntologyBiologicalProcess | negative regulation of hyaluronan biosynthetic process | 3.00e-04 | 4 | 147 | 2 | GO:1900126 | |
| GeneOntologyBiologicalProcess | xenobiotic transmembrane transport | 3.16e-04 | 19 | 147 | 3 | GO:0006855 | |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | ABL1 SLC37A3 KCNV2 PKD1L2 RYR3 SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A SCN10A SLC5A8 DMD SLC26A11 HSPA2 ANO3 | 3.39e-04 | 1017 | 147 | 18 | GO:0098660 |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | ABCC3 ABCC4 ABL1 KCNV2 PKD1L2 RYR3 ABCB1 SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A SCN10A DMD SLC26A11 HSPA2 ANO3 | 3.69e-04 | 1115 | 147 | 19 | GO:0034220 |
| GeneOntologyBiologicalProcess | glycoside transport | 4.97e-04 | 5 | 147 | 2 | GO:1901656 | |
| GeneOntologyCellularComponent | voltage-gated sodium channel complex | 1.27e-13 | 17 | 149 | 8 | GO:0001518 | |
| GeneOntologyCellularComponent | sodium channel complex | 2.08e-11 | 29 | 149 | 8 | GO:0034706 | |
| GeneOntologyCellularComponent | cation channel complex | KCNV2 RYR3 SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A SCN10A HSPA2 | 1.01e-06 | 235 | 149 | 11 | GO:0034703 |
| GeneOntologyCellularComponent | monoatomic ion channel complex | KCNV2 RYR3 SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A SCN10A HSPA2 | 8.70e-05 | 378 | 149 | 11 | GO:0034702 |
| GeneOntologyCellularComponent | laminin-3 complex | 1.51e-04 | 3 | 149 | 2 | GO:0005608 | |
| GeneOntologyCellularComponent | USH2 complex | 3.00e-04 | 4 | 149 | 2 | GO:1990696 | |
| GeneOntologyCellularComponent | node of Ranvier | 3.70e-04 | 20 | 149 | 3 | GO:0033268 | |
| GeneOntologyCellularComponent | transmembrane transporter complex | KCNV2 RYR3 NDUFA12 SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A SCN10A HSPA2 | 3.78e-04 | 523 | 149 | 12 | GO:1902495 |
| GeneOntologyCellularComponent | transporter complex | KCNV2 RYR3 NDUFA12 SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A SCN10A HSPA2 | 5.91e-04 | 550 | 149 | 12 | GO:1990351 |
| GeneOntologyCellularComponent | stereocilia ankle link | 7.43e-04 | 6 | 149 | 2 | GO:0002141 | |
| GeneOntologyCellularComponent | stereocilia ankle link complex | 7.43e-04 | 6 | 149 | 2 | GO:0002142 | |
| GeneOntologyCellularComponent | external side of apical plasma membrane | 7.43e-04 | 6 | 149 | 2 | GO:0098591 | |
| GeneOntologyCellularComponent | axon initial segment | 1.13e-03 | 29 | 149 | 3 | GO:0043194 | |
| GeneOntologyCellularComponent | trans-Golgi network membrane | 1.25e-03 | 112 | 149 | 5 | GO:0032588 | |
| GeneOntologyCellularComponent | stereocilia coupling link | 1.37e-03 | 8 | 149 | 2 | GO:0002139 | |
| GeneOntologyCellularComponent | Barr body | 1.37e-03 | 8 | 149 | 2 | GO:0001740 | |
| GeneOntologyCellularComponent | plasma membrane protein complex | KCNV2 AP2A1 SCN1A SCN2A SCN3A SCN4A SCN5A CLTC SCN8A SCN9A SCN10A DMD HSPA2 SNTB2 | 1.49e-03 | 785 | 149 | 14 | GO:0098797 |
| GeneOntologyCellularComponent | clathrin complex | 1.76e-03 | 9 | 149 | 2 | GO:0071439 | |
| GeneOntologyCellularComponent | Golgi membrane | KRAS SGMS2 NRAS ST3GAL3 NLRP3 ABCB1 SLC50A1 HRAS B4GALNT2 TNKS2 COG5 HS3ST2 VPS13B | 1.99e-03 | 721 | 149 | 13 | GO:0000139 |
| GeneOntologyCellularComponent | sarcomere | 2.09e-03 | 249 | 149 | 7 | GO:0030017 | |
| GeneOntologyCellularComponent | laminin complex | 2.19e-03 | 10 | 149 | 2 | GO:0043256 | |
| GeneOntologyCellularComponent | sarcolemma | 2.44e-03 | 190 | 149 | 6 | GO:0042383 | |
| GeneOntologyCellularComponent | T-tubule | 2.46e-03 | 79 | 149 | 4 | GO:0030315 | |
| GeneOntologyCellularComponent | postsynaptic endocytic zone | 2.66e-03 | 11 | 149 | 2 | GO:0098843 | |
| HumanPheno | Linear nevus sebaceous | 2.08e-06 | 3 | 66 | 3 | HP:0010817 | |
| HumanPheno | Obsessive-compulsive trait | 3.16e-06 | 33 | 66 | 6 | HP:0008770 | |
| HumanPheno | Generalized cerebral atrophy/hypoplasia | 1.68e-05 | 13 | 66 | 4 | HP:0007058 | |
| HumanPheno | Nevus sebaceous | 2.04e-05 | 5 | 66 | 3 | HP:0010815 | |
| HumanPheno | Compulsive behaviors | FMO3 ASH1L ADGRV1 ARID1B SCN1A SCN2A SCN8A SCN9A PDZD8 EP300 | 2.93e-05 | 158 | 66 | 10 | HP:0000722 |
| HumanPheno | Complex febrile seizure | 4.16e-05 | 16 | 66 | 4 | HP:0011172 | |
| HumanPheno | Atypical absence status epilepticus | 5.39e-05 | 17 | 66 | 4 | HP:0011151 | |
| HumanPheno | Abnormality of dental color | 6.52e-05 | 34 | 66 | 5 | HP:0011073 | |
| HumanPheno | Generalized non-convulsive status epilepticus without coma | 6.86e-05 | 18 | 66 | 4 | HP:0032860 | |
| HumanPheno | Non-convulsive status epilepticus without coma | 1.07e-04 | 20 | 66 | 4 | HP:0032671 | |
| HumanPheno | Photosensitive myoclonic seizure | 1.11e-04 | 8 | 66 | 3 | HP:0001327 | |
| HumanPheno | Cyanotic episode | 1.11e-04 | 8 | 66 | 3 | HP:0200048 | |
| HumanPheno | Abnormal knee physiology | 1.14e-04 | 87 | 66 | 7 | HP:0034670 | |
| HumanPheno | Talipes valgus | 1.30e-04 | 21 | 66 | 4 | HP:0004684 | |
| HumanPheno | Focal clonic seizure | 1.84e-04 | 42 | 66 | 5 | HP:0002266 | |
| HumanPheno | Tibial torsion | 1.89e-04 | 23 | 66 | 4 | HP:0100694 | |
| HumanPheno | Focal hemiclonic seizure | 2.65e-04 | 25 | 66 | 4 | HP:0006813 | |
| Domain | Na_channel_asu | 6.03e-16 | 10 | 149 | 8 | IPR001696 | |
| Domain | Na_trans_assoc | 6.03e-16 | 10 | 149 | 8 | IPR010526 | |
| Domain | Na_trans_assoc | 6.03e-16 | 10 | 149 | 8 | PF06512 | |
| Domain | Na_trans_cytopl | 2.33e-13 | 6 | 149 | 6 | PF11933 | |
| Domain | Na_trans_cytopl | 2.33e-13 | 6 | 149 | 6 | IPR024583 | |
| Domain | Channel_four-helix_dom | 6.66e-10 | 57 | 149 | 9 | IPR027359 | |
| Domain | - | 6.66e-10 | 57 | 149 | 9 | 1.20.120.350 | |
| Domain | Ion_trans_dom | 2.58e-08 | 114 | 149 | 10 | IPR005821 | |
| Domain | Ion_trans | 2.58e-08 | 114 | 149 | 10 | PF00520 | |
| Domain | IQ_motif_EF-hand-BS | 4.19e-08 | 90 | 149 | 9 | IPR000048 | |
| Domain | IQ | 5.59e-08 | 93 | 149 | 9 | PS50096 | |
| Domain | IQ | 2.67e-07 | 81 | 149 | 8 | SM00015 | |
| Domain | P-loop_NTPase | KRAS ABCC3 ABCC4 NRAS CENPE ABCB5 RNF213 GTPBP10 NLRP3 ABCB1 ARFRP1 SEPTIN3 RAB4B ABCB10 MTIF2 UCKL1 HRAS HFM1 DDX43 PALS2 HS3ST2 HYDIN | 1.03e-06 | 848 | 149 | 22 | IPR027417 |
| Domain | ABC_membrane | 1.14e-06 | 24 | 149 | 5 | PF00664 | |
| Domain | IQ | 1.55e-06 | 71 | 149 | 7 | PF00612 | |
| Domain | - | KRAS ABCC3 ABCC4 NRAS ABCB5 RNF213 GTPBP10 ABCB1 ARFRP1 SEPTIN3 RAB4B ABCB10 MTIF2 UCKL1 HRAS HFM1 DDX43 PALS2 HS3ST2 HYDIN | 2.05e-06 | 746 | 149 | 20 | 3.40.50.300 |
| Domain | ABC_TM1F | 2.56e-06 | 28 | 149 | 5 | PS50929 | |
| Domain | ABC1_TM_dom | 2.56e-06 | 28 | 149 | 5 | IPR011527 | |
| Domain | Sc_DH/Rdtase_CS | 8.09e-06 | 35 | 149 | 5 | IPR020904 | |
| Domain | ABC_transporter_CS | 2.03e-05 | 42 | 149 | 5 | IPR017871 | |
| Domain | ABC_tran | 3.92e-05 | 48 | 149 | 5 | PF00005 | |
| Domain | ABC_TRANSPORTER_2 | 3.92e-05 | 48 | 149 | 5 | PS50893 | |
| Domain | ABC_TRANSPORTER_1 | 4.34e-05 | 49 | 149 | 5 | PS00211 | |
| Domain | ABC_transporter-like | 4.79e-05 | 50 | 149 | 5 | IPR003439 | |
| Domain | Core_histone_macro-H2A | 6.32e-05 | 2 | 149 | 2 | IPR021171 | |
| Domain | ADH_SHORT | 6.37e-05 | 53 | 149 | 5 | PS00061 | |
| Domain | adh_short | 7.62e-05 | 55 | 149 | 5 | PF00106 | |
| Domain | SDR_fam | 8.32e-05 | 56 | 149 | 5 | IPR002347 | |
| Domain | SHR-BD | 3.75e-04 | 4 | 149 | 2 | IPR009543 | |
| Domain | VPS13_C | 3.75e-04 | 4 | 149 | 2 | PF16909 | |
| Domain | VPS13_C | 3.75e-04 | 4 | 149 | 2 | IPR031645 | |
| Domain | SHR-BD | 3.75e-04 | 4 | 149 | 2 | PF06650 | |
| Domain | AAA | 1.05e-03 | 144 | 149 | 6 | SM00382 | |
| Domain | AAA+_ATPase | 1.05e-03 | 144 | 149 | 6 | IPR003593 | |
| Pathway | REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS | 6.70e-11 | 31 | 109 | 8 | M877 | |
| Pathway | REACTOME_PHASE_0_RAPID_DEPOLARISATION | 8.88e-11 | 32 | 109 | 8 | M27455 | |
| Pathway | REACTOME_L1CAM_INTERACTIONS | LAMA1 AP2A1 SCN1A SCN2A SCN3A SCN4A SCN5A CLTC SCN8A SCN9A SCN10A | 2.22e-09 | 121 | 109 | 11 | M872 |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | KRAS ABL1 NRAS PSMA6 LAMA1 ARHGEF12 RPS28 ADGRV1 PFN1 DSCAML1 AP2A1 SCN1A SCN2A SCN3A SCN4A SCN5A CLTC SCN8A SCN9A SCN10A HRAS | 2.44e-09 | 575 | 109 | 21 | M29853 |
| Pathway | REACTOME_MUSCLE_CONTRACTION | RYR3 SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A SCN10A ALDH2 DMD | 4.72e-07 | 203 | 109 | 11 | M5485 |
| Pathway | REACTOME_CARDIAC_CONDUCTION | 7.15e-07 | 130 | 109 | 9 | M27454 | |
| Pathway | WP_DRAVET_SYNDROME | 2.15e-06 | 28 | 109 | 5 | M45519 | |
| Pathway | REACTOME_P38MAPK_EVENTS | 2.29e-06 | 13 | 109 | 4 | M1441 | |
| Pathway | KEGG_MEDICUS_VARIANT_BCR_ABL_FUSION_KINASE_TO_RAS_ERK_SIGNALING_PATHWAY | 3.19e-06 | 14 | 109 | 4 | M47364 | |
| Pathway | REACTOME_ACTIVATION_OF_RAS_IN_B_CELLS | 4.45e-06 | 5 | 109 | 3 | M26921 | |
| Pathway | REACTOME_ESTROGEN_STIMULATED_SIGNALING_THROUGH_PRKCZ | 8.84e-06 | 6 | 109 | 3 | M27951 | |
| Pathway | KEGG_MEDICUS_VARIANT_LOSS_OF_RASSF1_TO_RAS_RASSF1_SIGNALING_PATHWAY | 8.84e-06 | 6 | 109 | 3 | M47433 | |
| Pathway | KEGG_MEDICUS_REFERENCE_REGULATION_OF_GF_RTK_RAS_ERK_SIGNALING_RAS_UBIQUITINATION_BY_CUL3_COMPLEX | 8.84e-06 | 6 | 109 | 3 | M47931 | |
| Pathway | KEGG_MEDICUS_REFERENCE_REGULATION_OF_GF_RTK_RAS_ERK_SIGNALING_SPRED_AND_NF1 | 8.84e-06 | 6 | 109 | 3 | M47932 | |
| Pathway | REACTOME_SHC_MEDIATED_CASCADE_FGFR3 | 9.52e-06 | 18 | 109 | 4 | M27518 | |
| Pathway | REACTOME_FRS_MEDIATED_FGFR3_SIGNALING | 1.49e-05 | 20 | 109 | 4 | M27519 | |
| Pathway | REACTOME_SIGNALLING_TO_RAS | 1.49e-05 | 20 | 109 | 4 | M12256 | |
| Pathway | WP_SEROTONIN_RECEPTOR_2_AND_ELKSRFGATA4_SIGNALING | 1.49e-05 | 20 | 109 | 4 | M39485 | |
| Pathway | REACTOME_RAS_SIGNALING_DOWNSTREAM_OF_NF1_LOSS_OF_FUNCTION_VARIANTS | 1.54e-05 | 7 | 109 | 3 | M29717 | |
| Pathway | REACTOME_SOS_MEDIATED_SIGNALLING | 1.54e-05 | 7 | 109 | 3 | M19489 | |
| Pathway | REACTOME_P38MAPK_EVENTS | 1.54e-05 | 7 | 109 | 3 | MM14672 | |
| Pathway | REACTOME_SHC_MEDIATED_CASCADE_FGFR1 | 1.83e-05 | 21 | 109 | 4 | M27511 | |
| Pathway | REACTOME_CD209_DC_SIGN_SIGNALING | 1.83e-05 | 21 | 109 | 4 | M27485 | |
| Pathway | KEGG_ABC_TRANSPORTERS | 2.15e-05 | 44 | 109 | 5 | M11911 | |
| Pathway | REACTOME_ACTIVATED_NTRK3_SIGNALS_THROUGH_RAS | 2.45e-05 | 8 | 109 | 3 | M27919 | |
| Pathway | KEGG_MEDICUS_REFERENCE_REGULATION_OF_GF_RTK_RAS_ERK_SIGNALING_RASGAP | 2.45e-05 | 8 | 109 | 3 | M47935 | |
| Pathway | REACTOME_FRS_MEDIATED_FGFR1_SIGNALING | 2.67e-05 | 23 | 109 | 4 | M27513 | |
| Pathway | REACTOME_SIGNALING_BY_MET | 3.27e-05 | 79 | 109 | 6 | M27643 | |
| Pathway | REACTOME_EGFR_TRANSACTIVATION_BY_GASTRIN | 3.65e-05 | 9 | 109 | 3 | M27156 | |
| Pathway | REACTOME_SHC_RELATED_EVENTS_TRIGGERED_BY_IGF1R | 3.65e-05 | 9 | 109 | 3 | M27173 | |
| Pathway | REACTOME_ACTIVATED_NTRK2_SIGNALS_THROUGH_RAS | 3.65e-05 | 9 | 109 | 3 | M27904 | |
| Pathway | REACTOME_FRS_MEDIATED_FGFR2_SIGNALING | 3.77e-05 | 25 | 109 | 4 | M27517 | |
| Pathway | REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR3 | 3.77e-05 | 25 | 109 | 4 | M27520 | |
| Pathway | REACTOME_SIGNALING_BY_FGFR4_IN_DISEASE | 7.09e-05 | 11 | 109 | 3 | M27535 | |
| Pathway | KEGG_MEDICUS_VARIANT_RET_FUSION_KINASE_TO_RAS_ERK_SIGNALING_PATHWAY | 7.09e-05 | 11 | 109 | 3 | M47370 | |
| Pathway | KEGG_MEDICUS_VARIANT_TRK_FUSION_KINASE_TO_RAS_ERK_SIGNALING_PATHWAY | 7.09e-05 | 11 | 109 | 3 | M47371 | |
| Pathway | REACTOME_ACTIVATED_NTRK2_SIGNALS_THROUGH_FRS2_AND_FRS3 | 7.09e-05 | 11 | 109 | 3 | M27911 | |
| Pathway | REACTOME_MET_ACTIVATES_RAS_SIGNALING | 7.09e-05 | 11 | 109 | 3 | M27740 | |
| Pathway | REACTOME_CONSTITUTIVE_SIGNALING_BY_OVEREXPRESSED_ERBB2 | 7.09e-05 | 11 | 109 | 3 | M29814 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_RALGDS_SIGNALING_PATHWAY | 7.09e-05 | 11 | 109 | 3 | M47436 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_RASSF1_SIGNALING_PATHWAY | 7.09e-05 | 11 | 109 | 3 | M47432 | |
| Pathway | REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR2 | 7.94e-05 | 30 | 109 | 4 | M27515 | |
| Pathway | REACTOME_SIGNALING_BY_NTRKS | 7.98e-05 | 134 | 109 | 7 | M3574 | |
| Pathway | REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR1 | 9.06e-05 | 31 | 109 | 4 | M27510 | |
| Pathway | KEGG_MEDICUS_VARIANT_EML4_ALK_FUSION_KINASE_TO_RAS_ERK_SIGNALING_PATHWAY | 9.40e-05 | 12 | 109 | 3 | M47369 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_METALS_TO_RAS_ERK_SIGNALING_PATHWAY | 9.40e-05 | 12 | 109 | 3 | M47815 | |
| Pathway | REACTOME_SIGNALLING_TO_RAS | 9.40e-05 | 12 | 109 | 3 | MM14657 | |
| Pathway | WP_ENTEROHEPATIC_CIRCULATION_OF_BILE_ACIDS | 9.40e-05 | 12 | 109 | 3 | M48096 | |
| Pathway | REACTOME_SIGNALING_BY_PDGFRA_TRANSMEMBRANE_JUXTAMEMBRANE_AND_KINASE_DOMAIN_MUTANTS | 9.40e-05 | 12 | 109 | 3 | M29851 | |
| Pathway | WP_RALA_DOWNSTREAM_REGULATED_GENES | 9.40e-05 | 12 | 109 | 3 | M39408 | |
| Pathway | WP_PI3KAKTMTOR_SIGNALING_AND_THERAPEUTIC_OPPORTUNITIES_IN_PROSTATE_CANCER | 1.03e-04 | 32 | 109 | 4 | M39445 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_JNK_SIGNALING_PATHWAY | 1.22e-04 | 13 | 109 | 3 | M47594 | |
| Pathway | REACTOME_SIGNALING_BY_NTRK1_TRKA | 1.24e-04 | 63 | 109 | 5 | MM14714 | |
| Pathway | WP_ADHD_AND_AUTISM_ASD_PATHWAYS | ABL1 RICTOR SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A SCN10A ALDH2 | 1.26e-04 | 367 | 109 | 11 | M48346 |
| Pathway | PID_MAPK_TRK_PATHWAY | 1.31e-04 | 34 | 109 | 4 | M270 | |
| Pathway | REACTOME_SIGNALLING_TO_ERKS | 1.31e-04 | 34 | 109 | 4 | M13881 | |
| Pathway | REACTOME_ABC_FAMILY_PROTEINS_MEDIATED_TRANSPORT | 1.45e-04 | 103 | 109 | 6 | M758 | |
| Pathway | KEGG_MEDICUS_REFERENCE_FGF_FGFR_RAS_ERK_SIGNALING_PATHWAY | 1.47e-04 | 35 | 109 | 4 | M47379 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_KIT_TO_RAS_ERK_SIGNALING_PATHWAY | 1.54e-04 | 14 | 109 | 3 | M47365 | |
| Pathway | KEGG_MEDICUS_VARIANT_DUPLICATION_OR_MUTATION_ACTIVATED_FLT3_TO_RAS_ERK_SIGNALING_PATHWAY | 1.54e-04 | 14 | 109 | 3 | M47366 | |
| Pathway | KEGG_MEDICUS_VARIANT_DUPLICATION_OR_MUTATION_ACTIVATED_FLT3_TO_RAS_PI3K_SIGNALING_PATHWAY | 1.54e-04 | 14 | 109 | 3 | M47390 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_PDGFR_TO_RAS_ERK_SIGNALING_PATHWAY | 1.54e-04 | 14 | 109 | 3 | M47378 | |
| Pathway | REACTOME_SHC1_EVENTS_IN_ERBB4_SIGNALING | 1.54e-04 | 14 | 109 | 3 | M569 | |
| Pathway | REACTOME_ERYTHROPOIETIN_ACTIVATES_RAS | 1.54e-04 | 14 | 109 | 3 | M27908 | |
| Pathway | REACTOME_PTK6_REGULATES_RHO_GTPASES_RAS_GTPASE_AND_MAP_KINASES | 1.54e-04 | 14 | 109 | 3 | M27734 | |
| Pathway | PID_TCR_RAS_PATHWAY | 1.54e-04 | 14 | 109 | 3 | M134 | |
| Pathway | KEGG_MEDICUS_VARIANT_MET_OVEREXPRESSION_TO_RAS_ERK_SIGNALING_PATHWAY | 1.54e-04 | 14 | 109 | 3 | M47488 | |
| Pathway | REACTOME_SHC1_EVENTS_IN_EGFR_SIGNALING | 1.54e-04 | 14 | 109 | 3 | M719 | |
| Pathway | REACTOME_CONSTITUTIVE_SIGNALING_BY_EGFRVIII | 1.91e-04 | 15 | 109 | 3 | M29701 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_MET_TO_RAS_ERK_SIGNALING_PATHWAY | 1.91e-04 | 15 | 109 | 3 | M47367 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_PI3K_SIGNALING_PATHWAY | 1.91e-04 | 15 | 109 | 3 | M47389 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_EGFR_TO_RAS_ERK_SIGNALING_PATHWAY | 1.91e-04 | 15 | 109 | 3 | M47375 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_FGFR_TO_RAS_ERK_SIGNALING_PATHWAY | 1.91e-04 | 15 | 109 | 3 | M47380 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_PYK2_RAS_ERK_SIGNALING_PATHWAY | 1.91e-04 | 15 | 109 | 3 | M47592 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HBV_HBX_TO_RAS_ERK_SIGNALING_PATHWAY | 1.91e-04 | 15 | 109 | 3 | M47593 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_FGF17_TO_RAS_ERK_SIGNALING_PATHWAY | 1.91e-04 | 15 | 109 | 3 | M47640 | |
| Pathway | KEGG_MEDICUS_VARIANT_IGF2_OVEREXPRESSION_TO_RAS_ERK_SIGNALING_PATHWAY | 1.91e-04 | 15 | 109 | 3 | M47485 | |
| Pathway | KEGG_MEDICUS_REFERENCE_HGF_MET_RAS_ERK_SIGNALING_PATHWAY | 1.91e-04 | 15 | 109 | 3 | M47473 | |
| Pathway | KEGG_MEDICUS_REFERENCE_FLT3LG_FLT3_RAS_ERK_SIGNALING_PATHWAY | 1.91e-04 | 15 | 109 | 3 | M47474 | |
| Pathway | KEGG_MEDICUS_REFERENCE_FLT3LG_FLT3_RAS_PI3K_SIGNALING_PATHWAY | 1.91e-04 | 15 | 109 | 3 | M47475 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TGFA_EGFR_RAS_ERK_SIGNALING_PATHWAY | 1.91e-04 | 15 | 109 | 3 | M47480 | |
| Pathway | KEGG_MEDICUS_VARIANT_EGF_OVEREXPRESSION_TO_RAS_ERK_SIGNALING_PATHWAY | 1.91e-04 | 15 | 109 | 3 | M47495 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EREG_EGFR_RAS_ERK_SIGNALING_PATHWAY | 1.91e-04 | 15 | 109 | 3 | M47496 | |
| Pathway | KEGG_MEDICUS_REFERENCE_AREG_EGFR_RAS_ERK_SIGNALING_PATHWAY | 1.91e-04 | 15 | 109 | 3 | M47497 | |
| Pathway | KEGG_MEDICUS_REFERENCE_KITLG_KIT_RAS_ERK_SIGNALING_PATHWAY | 1.91e-04 | 15 | 109 | 3 | M47472 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HCMV_GB_TO_PDGFR_RAS_ERK_SIGNALING_PATHWAY | 1.91e-04 | 15 | 109 | 3 | M47535 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E5_TO_EGFR_RAS_ERK_SIGNALING_PATHWAY | 1.91e-04 | 15 | 109 | 3 | M47531 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | KRAS ABL1 NRAS PSMA6 LAMA1 ARHGEF12 RPS28 ADGRV1 PFN1 DSCAML1 ARID1B AP2A1 SCN1A SCN2A SCN3A SCN4A SCN5A CLTC SCN8A SCN9A SCN10A HRAS PKLR EP300 | 2.00e-04 | 1432 | 109 | 24 | M509 |
| Pathway | REACTOME_SIGNALING_BY_FGFR1_IN_DISEASE | 2.04e-04 | 38 | 109 | 4 | M27536 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_ERK_SIGNALING_PATHWAY | 2.34e-04 | 16 | 109 | 3 | M47363 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_FGFR3_TO_RAS_ERK_SIGNALING_PATHWAY | 2.34e-04 | 16 | 109 | 3 | M47373 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_ERBB2_RAS_ERK_SIGNALING_PATHWAY | 2.34e-04 | 16 | 109 | 3 | M47381 | |
| Pathway | KEGG_MEDICUS_REFERENCE_P4_PR_RAS_ERK_SIGNALING_PATHWAY | 2.34e-04 | 16 | 109 | 3 | M47804 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_E2_TO_RAS_ERK_SIGNALING_PATHWAY | 2.34e-04 | 16 | 109 | 3 | M47801 | |
| Pathway | REACTOME_GRB2_EVENTS_IN_ERBB2_SIGNALING | 2.34e-04 | 16 | 109 | 3 | M562 | |
| Pathway | REACTOME_SIGNALING_BY_FLT3_ITD_AND_TKD_MUTANTS | 2.34e-04 | 16 | 109 | 3 | M41733 | |
| Pathway | KEGG_MEDICUS_REFERENCE_AGE_RAGE_SIGNALING_PATHWAY | 2.34e-04 | 16 | 109 | 3 | M47682 | |
| Pathway | REACTOME_SIGNALING_BY_ERBB2_ECD_MUTANTS | 2.34e-04 | 16 | 109 | 3 | M29847 | |
| Pathway | KEGG_MEDICUS_REFERENCE_IGF_IGF1R_RAS_ERK_SIGNALING_PATHWAY | 2.34e-04 | 16 | 109 | 3 | M47483 | |
| Pathway | REACTOME_SIGNALING_BY_FGFR3 | 2.49e-04 | 40 | 109 | 4 | M27532 | |
| Pubmed | 9.90e-19 | 9 | 152 | 8 | 16382098 | ||
| Pubmed | A 'toothache tree' alkylamide inhibits Aδ mechanonociceptors to alleviate mechanical pain. | 6.31e-15 | 6 | 152 | 6 | 23652591 | |
| Pubmed | 4.45e-14 | 13 | 152 | 7 | 15123669 | ||
| Pubmed | 5.24e-13 | 9 | 152 | 6 | 15746173 | ||
| Pubmed | 1.49e-12 | 5 | 152 | 5 | 17724025 | ||
| Pubmed | 8.27e-11 | 8 | 152 | 5 | 9412493 | ||
| Pubmed | 3.51e-10 | 4 | 152 | 4 | 17537961 | ||
| Pubmed | 3.51e-10 | 4 | 152 | 4 | 35031483 | ||
| Pubmed | 3.51e-10 | 4 | 152 | 4 | 29578003 | ||
| Pubmed | Tyrosine phosphorylation of RAS by ABL allosterically enhances effector binding. | 3.51e-10 | 4 | 152 | 4 | 25999467 | |
| Pubmed | Nav1.2 haplodeficiency in excitatory neurons causes absence-like seizures in mice. | 1.15e-09 | 12 | 152 | 5 | 30175250 | |
| Pubmed | 1.75e-09 | 5 | 152 | 4 | 8812438 | ||
| Pubmed | Early development of electrical excitability in the mouse enteric nervous system. | 1.75e-09 | 5 | 152 | 4 | 22875929 | |
| Pubmed | Genetic mapping of the peripheral sodium channel genes, Scn9a and Scn10a, in the mouse. | 4.34e-08 | 9 | 152 | 4 | 8854872 | |
| Pubmed | Diagnostic Value of RAS Mutations in Indeterminate Thyroid Nodules. | 8.18e-08 | 3 | 152 | 3 | 28116986 | |
| Pubmed | Mutations of RAS gene family in specimens of bladder cancer. | 8.18e-08 | 3 | 152 | 3 | 19101897 | |
| Pubmed | 8.18e-08 | 3 | 152 | 3 | 33620658 | ||
| Pubmed | 8.18e-08 | 3 | 152 | 3 | 22589270 | ||
| Pubmed | A requirement for wild-type Ras isoforms in mutant KRas-driven signalling and transformation. | 8.18e-08 | 3 | 152 | 3 | 23496764 | |
| Pubmed | Distribution of p21ras during primary palate formation of non-cleft and cleft strains of mice. | 8.18e-08 | 3 | 152 | 3 | 7776260 | |
| Pubmed | 8.18e-08 | 3 | 152 | 3 | 25788415 | ||
| Pubmed | 8.18e-08 | 3 | 152 | 3 | 12610651 | ||
| Pubmed | Comparison of liver oncogenic potential among human RAS isoforms. | 8.18e-08 | 3 | 152 | 3 | 26799184 | |
| Pubmed | 8.18e-08 | 3 | 152 | 3 | 31906952 | ||
| Pubmed | Partial functional overlap of the three ras genes in mouse embryonic development. | 8.18e-08 | 3 | 152 | 3 | 18059342 | |
| Pubmed | 8.18e-08 | 3 | 152 | 3 | 19699781 | ||
| Pubmed | 8.18e-08 | 3 | 152 | 3 | 18784617 | ||
| Pubmed | Evidence of a low prevalence of RAS mutations in a large medullary thyroid cancer series. | 8.18e-08 | 3 | 152 | 3 | 23240926 | |
| Pubmed | 8.18e-08 | 3 | 152 | 3 | 28518218 | ||
| Pubmed | Absolute Quantification of Endogenous Ras Isoform Abundance. | 8.18e-08 | 3 | 152 | 3 | 26560143 | |
| Pubmed | Further evidence for a somatic KRAS mutation in a pilocytic astrocytoma. | 8.18e-08 | 3 | 152 | 3 | 17712732 | |
| Pubmed | 8.18e-08 | 3 | 152 | 3 | 24222113 | ||
| Pubmed | Interactions between wild-type and mutant Ras genes in lung and skin carcinogenesis. | 8.18e-08 | 3 | 152 | 3 | 22945650 | |
| Pubmed | 8.18e-08 | 3 | 152 | 3 | 19303097 | ||
| Pubmed | 8.18e-08 | 3 | 152 | 3 | 27911734 | ||
| Pubmed | Absence of oncogenic mutations of RAS family genes in soft tissue sarcomas of 100 Japanese patients. | 8.18e-08 | 3 | 152 | 3 | 20150643 | |
| Pubmed | K-ras is an essential gene in the mouse with partial functional overlap with N-ras. | 8.18e-08 | 3 | 152 | 3 | 9334313 | |
| Pubmed | 8.18e-08 | 3 | 152 | 3 | 19284629 | ||
| Pubmed | RAS gene mutations and histomorphometric measurements in oral squamous cell carcinoma. | 8.18e-08 | 3 | 152 | 3 | 37013448 | |
| Pubmed | 8.18e-08 | 3 | 152 | 3 | 33895391 | ||
| Pubmed | 8.18e-08 | 3 | 152 | 3 | 23859570 | ||
| Pubmed | 8.18e-08 | 3 | 152 | 3 | 25977330 | ||
| Pubmed | 8.18e-08 | 3 | 152 | 3 | 28630043 | ||
| Pubmed | Overexpression of wild-type p21Ras plays a prominent role in colorectal cancer. | 8.18e-08 | 3 | 152 | 3 | 28259994 | |
| Pubmed | The variable phenotype and low-risk nature of RAS-positive thyroid nodules. | 8.18e-08 | 3 | 152 | 3 | 26253102 | |
| Pubmed | 8.18e-08 | 3 | 152 | 3 | 16573741 | ||
| Pubmed | Analysis of k-ras nuclear expression in fibroblasts and mesangial cells. | 8.18e-08 | 3 | 152 | 3 | 20090846 | |
| Pubmed | 8.18e-08 | 3 | 152 | 3 | 21737741 | ||
| Pubmed | 8.18e-08 | 3 | 152 | 3 | 17544618 | ||
| Pubmed | 8.18e-08 | 3 | 152 | 3 | 32845893 | ||
| Pubmed | 8.18e-08 | 3 | 152 | 3 | 20038812 | ||
| Pubmed | 8.18e-08 | 3 | 152 | 3 | 17943694 | ||
| Pubmed | 8.18e-08 | 3 | 152 | 3 | 28202657 | ||
| Pubmed | Mutational analysis of K-ras and Ras protein expression in larynx squamous cell carcinoma. | 8.18e-08 | 3 | 152 | 3 | 16761621 | |
| Pubmed | 8.18e-08 | 3 | 152 | 3 | 17928448 | ||
| Pubmed | 8.18e-08 | 3 | 152 | 3 | 14973256 | ||
| Pubmed | 8.18e-08 | 3 | 152 | 3 | 20971740 | ||
| Pubmed | 8.18e-08 | 3 | 152 | 3 | 27119512 | ||
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | KRAS UAP1 NRAS PSMA6 GART ASH1L RICTOR CCT4 PFN1 ARID1B AP2A1 CLTC SCN8A PALS2 HSPA2 IQGAP3 HYDIN | 1.03e-07 | 807 | 152 | 17 | 30575818 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | DIP2B CPAMD8 ABCC4 MAPKAPK2 ASH1L RNF213 MACROH2A1 VPS54 ST3GAL3 ADGRV1 PFKL SIL1 PCYOX1L KLHL9 TRNT1 THRB SUGP2 UCKL1 MACROH2A2 PALS2 EP300 VPS13B BRMS1 | 1.45e-07 | 1489 | 152 | 23 | 28611215 |
| Pubmed | Ras effectors and their role in mitogenesis and oncogenesis. | 1.69e-07 | 12 | 152 | 4 | 9297626 | |
| Pubmed | MTMR12 RNF213 RICTOR CCT4 ITPRID2 XRCC1 PAF1 POSTN ARID1B KLHL15 CLTC EFR3B PDZD8 NHS MACROH2A2 DMD HERC1 HSPA2 SNTB2 | 1.81e-07 | 1049 | 152 | 19 | 27880917 | |
| Pubmed | Large-scale analysis of ion channel gene expression in the mouse heart during perinatal development. | 1.92e-07 | 139 | 152 | 8 | 16985003 | |
| Pubmed | 3.26e-07 | 4 | 152 | 3 | 35801810 | ||
| Pubmed | 3.26e-07 | 4 | 152 | 3 | 10085069 | ||
| Pubmed | 3.26e-07 | 4 | 152 | 3 | 38849523 | ||
| Pubmed | 3.26e-07 | 4 | 152 | 3 | 21156207 | ||
| Pubmed | 3.26e-07 | 4 | 152 | 3 | 9674433 | ||
| Pubmed | Quantification of spatiotemporal patterns of Ras isoform expression during development. | 3.26e-07 | 4 | 152 | 3 | 28117393 | |
| Pubmed | Use of recombinant inbred strains for studying genetic determinants of responses to alcohol. | 3.26e-07 | 4 | 152 | 3 | 8974318 | |
| Pubmed | Targeted DNA Sequencing from Autism Spectrum Disorder Brains Implicates Multiple Genetic Mechanisms. | 3.26e-07 | 4 | 152 | 3 | 26637798 | |
| Pubmed | The RAS-Effector Interface: Isoform-Specific Differences in the Effector Binding Regions. | 3.26e-07 | 4 | 152 | 3 | 27936046 | |
| Pubmed | Reducing Pericyte-Derived Scarring Promotes Recovery after Spinal Cord Injury. | 3.26e-07 | 4 | 152 | 3 | 29502968 | |
| Pubmed | Activated Ras interacts with the Ral guanine nucleotide dissociation stimulator. | 3.26e-07 | 4 | 152 | 3 | 7972015 | |
| Pubmed | 3.26e-07 | 4 | 152 | 3 | 22260870 | ||
| Pubmed | 3.26e-07 | 4 | 152 | 3 | 10490827 | ||
| Pubmed | 3.26e-07 | 4 | 152 | 3 | 34948093 | ||
| Pubmed | Ras membrane orientation and nanodomain localization generate isoform diversity. | 3.26e-07 | 4 | 152 | 3 | 20080631 | |
| Pubmed | 8.13e-07 | 5 | 152 | 3 | 22982107 | ||
| Pubmed | 8.13e-07 | 5 | 152 | 3 | 24337656 | ||
| Pubmed | Transgenic models of lymphoid neoplasia and development of a pan-hematopoietic vector. | 8.13e-07 | 5 | 152 | 3 | 10498879 | |
| Pubmed | 8.13e-07 | 5 | 152 | 3 | 9069260 | ||
| Pubmed | 8.13e-07 | 5 | 152 | 3 | 1679748 | ||
| Pubmed | Pericyte-derived fibrotic scarring is conserved across diverse central nervous system lesions. | 8.13e-07 | 5 | 152 | 3 | 34535655 | |
| Pubmed | Impeded Nedd4-1-mediated Ras degradation underlies Ras-driven tumorigenesis. | 8.13e-07 | 5 | 152 | 3 | 24746824 | |
| Pubmed | Activated Ras induces lens epithelial cell hyperplasia but not premature differentiation. | 8.13e-07 | 5 | 152 | 3 | 15558479 | |
| Pubmed | Efflux protein expression in human stem cell-derived retinal pigment epithelial cells. | 8.13e-07 | 5 | 152 | 3 | 22272278 | |
| Pubmed | 1.54e-06 | 247 | 152 | 9 | 30713523 | ||
| Pubmed | Targeting RICTOR Sensitizes SMAD4-Negative Colon Cancer to Irinotecan. | 1.55e-06 | 183 | 152 | 8 | 31932471 | |
| Pubmed | Glutamate transporter Slc1a3 mediates inter-niche stem cell activation during skin growth. | 1.62e-06 | 6 | 152 | 3 | 29615452 | |
| Pubmed | 1.62e-06 | 6 | 152 | 3 | 9143501 | ||
| Pubmed | 1.62e-06 | 6 | 152 | 3 | 16029194 | ||
| Pubmed | 1.62e-06 | 6 | 152 | 3 | 9753431 | ||
| Pubmed | 1.62e-06 | 6 | 152 | 3 | 23711479 | ||
| Pubmed | 1.62e-06 | 6 | 152 | 3 | 21072204 | ||
| Pubmed | 1.62e-06 | 6 | 152 | 3 | 10882715 | ||
| Pubmed | LZTR1 facilitates polyubiquitination and degradation of RAS-GTPases. | 1.62e-06 | 6 | 152 | 3 | 31337872 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | ABCC3 ABL1 KMT2B SLC37A3 MAPKAPK2 LAMB2 SIL1 AP2A1 SUGP2 UCKL1 SCN5A SCN8A PDZD8 WDFY3 HERC1 IQGAP3 EP300 ZNF687 | 1.77e-06 | 1105 | 152 | 18 | 35748872 |
| Pubmed | 2.14e-06 | 257 | 152 | 9 | 30945288 | ||
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | DDAH1 BDH2 ARHGEF12 ADGRV1 PFKL PFN1 ABCB1 VPS13D CLTC SCN10A PKLR ALDH2 SLC5A8 SLC26A11 HSPA2 GAA SECTM1 | 2.45e-06 | 1016 | 152 | 17 | 19056867 |
| Interaction | SCN11A interactions | 6.46e-08 | 15 | 152 | 5 | int:SCN11A | |
| Interaction | TRPV2 interactions | 6.31e-07 | 10 | 152 | 4 | int:TRPV2 | |
| Interaction | NEDD4 interactions | KRAS ABL1 NRAS PFN1 KHSRP ABCB1 SCN1A SCN2A SCN3A SCN5A CLTC SCN8A SCN9A SCN10A HRAS DMD EP300 | 7.91e-07 | 544 | 152 | 17 | int:NEDD4 |
| Interaction | SCN5A interactions | 1.39e-06 | 47 | 152 | 6 | int:SCN5A | |
| Interaction | HEPH interactions | 8.27e-06 | 6 | 152 | 3 | int:HEPH | |
| Interaction | SCN4B interactions | 2.29e-05 | 8 | 152 | 3 | int:SCN4B | |
| Interaction | CACNA1D interactions | 2.94e-05 | 24 | 152 | 4 | int:CACNA1D | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1q22 | 9.44e-05 | 71 | 152 | 4 | chr1q22 | |
| GeneFamily | Sodium voltage-gated channel alpha subunits | 6.40e-18 | 9 | 101 | 8 | 1203 | |
| GeneFamily | ATP binding cassette subfamily B | 2.70e-05 | 11 | 101 | 3 | 806 | |
| GeneFamily | Short chain dehydrogenase/reductase superfamily | 6.64e-05 | 76 | 101 | 5 | 743 | |
| GeneFamily | Fibronectin type III domain containing|USH2 complex | 1.84e-04 | 4 | 101 | 2 | 1244 | |
| GeneFamily | RAS type GTPase family | 6.79e-04 | 31 | 101 | 3 | 389 | |
| GeneFamily | PDZ domain containing | 1.63e-03 | 152 | 101 | 5 | 1220 | |
| GeneFamily | Laminin subunits | 1.97e-03 | 12 | 101 | 2 | 626 | |
| GeneFamily | ATP binding cassette subfamily C | 2.32e-03 | 13 | 101 | 2 | 807 | |
| GeneFamily | Beta 4-glycosyltransferases | 3.98e-03 | 17 | 101 | 2 | 425 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 4.46e-03 | 18 | 101 | 2 | 91 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ZAN LAMA1 ADGRV1 PKD1L2 DSCAML1 RYR3 SCN2A SCN9A DMD ANO3 HYDIN | 4.16e-11 | 184 | 152 | 11 | 2cbed6462fea2622871bb7e49b0df3d984239281 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ZAN LAMA1 ADGRV1 PKD1L2 DSCAML1 RYR3 SCN2A SCN9A DMD ANO3 HYDIN | 4.16e-11 | 184 | 152 | 11 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ZAN LAMA1 ADGRV1 PKD1L2 DSCAML1 RYR3 SCN2A SCN9A DMD ANO3 HYDIN | 4.16e-11 | 184 | 152 | 11 | 2b19a8c5f823e00812908b23e66bb4e563278aff |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 2.94e-08 | 199 | 152 | 9 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | 390C-Fibroblasts-Fibroblast-B_(Myofibroblast)|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.70e-07 | 176 | 152 | 8 | 852d3da0907fe87c0ef23d75a63ce07619cf0c54 | |
| ToppCell | 390C-Fibroblasts-Fibroblast-B_(Myofibroblast)-|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.70e-07 | 176 | 152 | 8 | d2df1e435996c51213e88270af9f928e9e09a6f5 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma|TCGA-Brain / Sample_Type by Project: Shred V9 | 2.59e-06 | 177 | 152 | 7 | e8ab340b20cd41554c3841fe980e078e878af35f | |
| ToppCell | COVID-19-kidney-PCT-S1|kidney / Disease (COVID-19 only), tissue and cell type | 3.35e-06 | 184 | 152 | 7 | 51ed1ebfdef45149541917c66cbacad87072e51f | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.60e-06 | 186 | 152 | 7 | f28d72b47624b69a580b4429e2be560a26898591 | |
| ToppCell | (04)_Pre-ciliated-(3)_72hpi|(04)_Pre-ciliated / shred by cell type and Timepoint | 3.86e-06 | 188 | 152 | 7 | f911dc61b008b60aaa2a1e9354085f480a669e2c | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.86e-06 | 188 | 152 | 7 | af740fa78542438fdff627ea1f74f4eee43316be | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 4.59e-06 | 193 | 152 | 7 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.25e-06 | 197 | 152 | 7 | 7e93a97b5ac5ae2f77a4b3141082a1463fed00dd | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.61e-06 | 199 | 152 | 7 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | Neuronal-Excitatory-eF(C1QL3)|Neuronal / cells hierarchy compared to all cells using T-Statistic | 5.79e-06 | 200 | 152 | 7 | 7668ae7ed550583ab59e419c5c9bb9f2d7e8e0d5 | |
| ToppCell | Neuronal-Excitatory-eF(C1QL3)----L5-6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 5.79e-06 | 200 | 152 | 7 | 44f0278cb0e4ffcda4af3719d7f5819a10929b9f | |
| ToppCell | Neuronal-Excitatory-eF(C1QL3)---|Neuronal / cells hierarchy compared to all cells using T-Statistic | 5.79e-06 | 200 | 152 | 7 | 23da7790e09575b2ca909ed16806b44223bf1017 | |
| ToppCell | Neuronal-Excitatory-eF(C1QL3)-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 5.79e-06 | 200 | 152 | 7 | 91f3df1c5a661ff703835f58a35cee93f18eb15c | |
| ToppCell | Neuronal-Excitatory-eF(C1QL3)--|Neuronal / cells hierarchy compared to all cells using T-Statistic | 5.79e-06 | 200 | 152 | 7 | 2e2b1d252972b702ade25526ec8461bf613d81b0 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.86e-05 | 160 | 152 | 6 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | 390C-Fibroblasts-Fibroblast-B_(Myofibroblast)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.86e-05 | 160 | 152 | 6 | 636127753e3a22831f39d4c8170df40901e4329d | |
| ToppCell | 390C-Fibroblasts-Fibroblast-B_(Myofibroblast)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.86e-05 | 160 | 152 | 6 | cb8d0dc1a6c69c7a85c5fdd8f0f6cca1b73dfc63 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.86e-05 | 160 | 152 | 6 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.93e-05 | 161 | 152 | 6 | 4f25eeabb841b0b9204cdd4e71d5e131e7868184 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.93e-05 | 161 | 152 | 6 | a006491c991e6a134be20ad75092a91f3b7c3c91 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Degenerative_Descending_Thin_Limb_Cell_Type_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.14e-05 | 164 | 152 | 6 | 1cb5fbd7050650047ad6f2ca792118e98d58d22b | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Connecting_Tubule_Intercalated_Cell_Type_A|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.37e-05 | 167 | 152 | 6 | edc5f04584b44f99ff9a62bbe0dab6fc044fb334 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.53e-05 | 169 | 152 | 6 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | 10x3'2.3-week_17-19-Myeloid_DC-DC-tDC|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.71e-05 | 171 | 152 | 6 | b327fb7813a3cdae06c8a4f8a0c256e9a20132f6 | |
| ToppCell | facs-Trachea-18m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l20-1|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.98e-05 | 174 | 152 | 6 | 1d157f7a919c8246e83d8060d2a0017c6c781ef3 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.18e-05 | 176 | 152 | 6 | 0710689e66deba179b0a8038cdd56b4834984f12 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.18e-05 | 176 | 152 | 6 | b4a23d8d1414434adeb237a96f28c825f1aebd77 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.18e-05 | 176 | 152 | 6 | 66c9c6b59030f67e8d746a9c6930e50923f2ded1 | |
| ToppCell | P15-Epithelial-epithelial_progenitor_cell-epithelial_unknown_3|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.18e-05 | 176 | 152 | 6 | 792f414f5092aba14260b8e16378e793a822498e | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6-Exc_L6_THEMIS_LINC00343|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.39e-05 | 178 | 152 | 6 | 6f61490d79cd1727ed2d5cc673823dd4efdafac1 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Neuronal-neurons_B-Branch_B2_(eMN)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.50e-05 | 179 | 152 | 6 | 228d12ed1c8dc92aefbcea4aaf7d108783c22be0 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_FAM150B|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.72e-05 | 181 | 152 | 6 | af92b8b7f455210dab502ef6964f3a0162180759 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L3-4_PVALB_HOMER3|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.72e-05 | 181 | 152 | 6 | bd7e9437839bca543ca5945df43d6525e6a312a8 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.95e-05 | 183 | 152 | 6 | 121791ef84e7ce377ed6f5b7953af8865e04958e | |
| ToppCell | COVID-19-kidney-PCT-S1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.95e-05 | 183 | 152 | 6 | 6878d14026c3df6aa12e45dfad94b32fa9d9b0b7 | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 3.95e-05 | 183 | 152 | 6 | c5b10571599dc26476170b54b53f09c23e6b3117 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.08e-05 | 184 | 152 | 6 | 102105ae1a5ef6d42a43f6d9b00f12ed0690ddb7 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L3-4_PVALB_HOMER3|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.33e-05 | 186 | 152 | 6 | 948815663c212c4311329d503b5991cbbbff9808 | |
| ToppCell | CV-Moderate-7|CV / Virus stimulation, Condition and Cluster | 4.33e-05 | 186 | 152 | 6 | 8571956890fc9894d766ba294a28e376b4aba428 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.33e-05 | 186 | 152 | 6 | f0c8de4f6ae9047b9108a47a2af8c5f42bc103b0 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.46e-05 | 187 | 152 | 6 | 7b2cd0c618ed081223343f3bec2244c8723c9a31 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Degenerative_Descending_Thin_Limb_Cell_Type_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.46e-05 | 187 | 152 | 6 | c31130fc2f9f882944b2ba366a034a03f051c4b9 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.46e-05 | 187 | 152 | 6 | e3095455d2f255854f339f6b05fa87852af0700f | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.73e-05 | 189 | 152 | 6 | 3b48b0d220cc24d5170713d61fa91f5bb6c21841 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.73e-05 | 189 | 152 | 6 | 78cf414b98bcb19deb934409acddaad1cd51b67f | |
| ToppCell | facs-Brain_Myeloid-Striatum-3m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.73e-05 | 189 | 152 | 6 | 875df61ee48baa5142ba4d2427bdec1c53e5a828 | |
| ToppCell | MS-CD8-antiviral_CD4|MS / Condition, Cell_class and T cell subcluster | 4.87e-05 | 190 | 152 | 6 | 8c831c4560b8e70f92b4c15644fea39f7f7afcf2 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.02e-05 | 191 | 152 | 6 | d0e9afe7b6334dd515d3e68892efdc76347a55e5 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_secretory_(0)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 5.02e-05 | 191 | 152 | 6 | 60ff989fe99d243a3d52955223680cdd1f1917a4 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.17e-05 | 192 | 152 | 6 | c618ede75dce3988c87a5b8f98d8e94e1dd66efd | |
| ToppCell | MS-Treg-exh_CD4|MS / Condition, Cell_class and T cell subcluster | 5.17e-05 | 192 | 152 | 6 | c6722bf142c84ccedd99c1a3344085aecb4cbab4 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.32e-05 | 193 | 152 | 6 | a3636c35ed25aabe2f1aba016c9fe125327bbfaf | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_airway|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 5.32e-05 | 193 | 152 | 6 | af6ec2c2ba92aef3e41531c3c7215b3300437bd9 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.47e-05 | 194 | 152 | 6 | e577d9e88390b36b5a09b97fe1026089892275a3 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.13e-05 | 198 | 152 | 6 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_neuro-secretory-Neuroendocrine|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.13e-05 | 198 | 152 | 6 | 8f25e8dff42bad8e779ca618bdb1cb1610667962 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.13e-05 | 198 | 152 | 6 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.13e-05 | 198 | 152 | 6 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 6.13e-05 | 198 | 152 | 6 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.13e-05 | 198 | 152 | 6 | 0ff30edfd3c133a42e8cb96e1631a1143215f808 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.30e-05 | 199 | 152 | 6 | 19a97e27a4758e794ce7246d295e112b47931a48 | |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | 6.48e-05 | 200 | 152 | 6 | 48d801219bc771d6c7e151dc88ca4c179988de85 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Alv_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 6.48e-05 | 200 | 152 | 6 | 66f7e8ee63c828f17468e79a4b816346b33e8980 | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.40e-04 | 145 | 152 | 5 | 96712c68ab759d7ade0d912581a1a7c25dc6def8 | |
| Drug | APETx1, Anthopleura elegantissima | 7.17e-11 | 6 | 151 | 5 | ctd:C475726 | |
| Drug | Zonisamide | 8.97e-10 | 17 | 151 | 6 | DB00909 | |
| Drug | PAK-104P | 3.42e-08 | 15 | 151 | 5 | CID000131368 | |
| Drug | 5-hydroxypropafenone | 8.89e-08 | 34 | 151 | 6 | CID000107927 | |
| Drug | 2,3,5,6-tetrafluoro-4-methylbenzyl (Z)-(1RS)-cis-3-(2-chloro-3,3,3-trifluoroprop-1-enyl)-2,2-dimethylcyclopropanecarboxylate | 1.27e-07 | 8 | 151 | 4 | ctd:C489827 | |
| Drug | Mexiletine | 2.28e-07 | 9 | 151 | 4 | ctd:D008801 | |
| Drug | N-(2-methyl-3-(4-(4-(4-(trifluoromethoxy)benzyloxy)piperidin-1-yl)-1,3,5-triazin-2-ylamino)phenyl)acetamide | 2.86e-07 | 3 | 151 | 3 | ctd:C561228 | |
| Drug | Pirmenolum | 7.06e-07 | 26 | 151 | 5 | CID000004853 | |
| Drug | AC1L1MOZ | 8.62e-07 | 27 | 151 | 5 | CID000031958 | |
| Drug | lamotrigine | 1.08e-06 | 116 | 151 | 8 | CID000003878 | |
| Drug | Lidocaine | 1.14e-06 | 4 | 151 | 3 | DB00281 | |
| Drug | APETx2 protein, Anthopleura elegantissima | 1.14e-06 | 4 | 151 | 3 | ctd:C501880 | |
| Drug | L 744832 | 1.14e-06 | 4 | 151 | 3 | ctd:C096898 | |
| Drug | cyfluthrin | 1.25e-06 | 29 | 151 | 5 | ctd:C052570 | |
| Drug | amiodarone | 1.26e-06 | 160 | 151 | 9 | CID000002156 | |
| Drug | 5-carboxyfluorescein diacetate | 1.27e-06 | 13 | 151 | 4 | CID000133314 | |
| Drug | Sodium | 1.45e-06 | 84 | 151 | 7 | ctd:D012964 | |
| Drug | tocainide | 1.50e-06 | 30 | 151 | 5 | CID000038945 | |
| Drug | tetramethylrosamine | 1.77e-06 | 14 | 151 | 4 | CID000443313 | |
| Drug | AC1NSZ76 | 2.83e-06 | 5 | 151 | 3 | CID005320215 | |
| Drug | AC1L4BIC | 3.18e-06 | 16 | 151 | 4 | CID000153998 | |
| Drug | propafenone | 4.10e-06 | 98 | 151 | 7 | CID000004932 | |
| Drug | benzocaine | 4.41e-06 | 37 | 151 | 5 | CID000002337 | |
| Drug | AC1L1CQC | 4.61e-06 | 65 | 151 | 6 | CID000002012 | |
| Drug | procainamide | MACROH2A1 SCN3A SCN4A SCN5A SCN9A SCN10A H1-6 MACROH2A2 WDFY3 | 5.17e-06 | 190 | 151 | 9 | CID000004913 |
| Drug | Scorpion Venoms | 5.29e-06 | 18 | 151 | 4 | ctd:D012604 | |
| Drug | NSC695241 | 5.64e-06 | 6 | 151 | 3 | CID000003584 | |
| Drug | fenpropathrin | 5.64e-06 | 6 | 151 | 3 | ctd:C044267 | |
| Drug | Tetrodotoxin | 6.55e-06 | 40 | 151 | 5 | ctd:D013779 | |
| Drug | Apa-sg | 6.67e-06 | 19 | 151 | 4 | CID000126348 | |
| Drug | diprafenone | 6.67e-06 | 19 | 151 | 4 | CID000071249 | |
| Drug | flecainide | 7.73e-06 | 71 | 151 | 6 | CID000003355 | |
| Drug | O746 | 8.29e-06 | 20 | 151 | 4 | CID006327063 | |
| Drug | 1, 3-diallylurea | 9.84e-06 | 74 | 151 | 6 | CID000074537 | |
| Drug | lidocaine | 1.18e-05 | 160 | 151 | 8 | CID000003676 | |
| Drug | amsacrine | 1.18e-05 | 45 | 151 | 5 | CID000002179 | |
| Drug | AC1Q5X3R | 1.24e-05 | 22 | 151 | 4 | CID000108075 | |
| Drug | VX-710 | 1.24e-05 | 22 | 151 | 4 | CID000406509 | |
| Drug | pilsicainide | 1.32e-05 | 46 | 151 | 5 | CID000004820 | |
| Drug | hydroxyrubicin | 1.49e-05 | 23 | 151 | 4 | CID000072398 | |
| Drug | calcein AM | 1.56e-05 | 8 | 151 | 3 | ctd:C085925 | |
| Drug | nicotine glucuronide | 1.56e-05 | 8 | 151 | 3 | CID003035848 | |
| Drug | tXMP | 1.56e-05 | 8 | 151 | 3 | CID003081384 | |
| Drug | AC1NT1AF | 2.11e-05 | 25 | 151 | 4 | CID005322157 | |
| Drug | So324 | 2.33e-05 | 9 | 151 | 3 | CID000462261 | |
| Drug | AC1L32OA | 2.33e-05 | 9 | 151 | 3 | CID000107745 | |
| Drug | verapamil | ABCC3 ABCC4 KCNV2 ABCB5 PAF1 RYR3 ABCB1 ABCB10 SCN3A SCN4A SCN5A SCN9A SCN10A | 2.45e-05 | 490 | 151 | 13 | CID000002520 |
| Drug | carbamazepine | 2.66e-05 | 179 | 151 | 8 | CID000002554 | |
| Drug | PbTx-1 | 2.90e-05 | 27 | 151 | 4 | CID006437089 | |
| Drug | nefopam | 2.90e-05 | 27 | 151 | 4 | CID000004450 | |
| Drug | thioxanthene | 3.32e-05 | 10 | 151 | 3 | CID000067495 | |
| Drug | Texas Red | 3.36e-05 | 28 | 151 | 4 | CID000452705 | |
| Drug | paraben | 3.36e-05 | 28 | 151 | 4 | CID000007175 | |
| Drug | Hexylcaine | 4.37e-05 | 2 | 151 | 2 | DB00473 | |
| Drug | mesochlorin e6 monoethylenediamine | 4.37e-05 | 2 | 151 | 2 | CID005488855 | |
| Drug | Ranolazine | 4.37e-05 | 2 | 151 | 2 | DB00243 | |
| Drug | Phenytoin | 4.37e-05 | 2 | 151 | 2 | DB00252 | |
| Drug | taxuspine C | 4.37e-05 | 2 | 151 | 2 | CID005321745 | |
| Drug | Flecainide | 4.37e-05 | 2 | 151 | 2 | DB01195 | |
| Drug | isoprene | 4.37e-05 | 2 | 151 | 2 | ctd:C005059 | |
| Drug | 2,2-diphenyl-1,3-dioxolane | 4.37e-05 | 2 | 151 | 2 | CID000283230 | |
| Drug | Ro44-5912 | 4.37e-05 | 2 | 151 | 2 | CID000197370 | |
| Drug | mu-conotoxin KIIIA, Conus kinoshitai | 4.37e-05 | 2 | 151 | 2 | ctd:C502265 | |
| Drug | 8-(3,3-dimethylallyl)chrysin | 4.37e-05 | 2 | 151 | 2 | CID005281903 | |
| Drug | AC1L8LCS | 4.37e-05 | 2 | 151 | 2 | CID000383419 | |
| Drug | sulfurmycin A | 4.37e-05 | 2 | 151 | 2 | CID000155836 | |
| Drug | DAPDOX | 4.37e-05 | 2 | 151 | 2 | CID000164413 | |
| Drug | AC1Q6JJG | 4.37e-05 | 2 | 151 | 2 | CID000164322 | |
| Drug | YM212 | 4.37e-05 | 2 | 151 | 2 | CID000129980 | |
| Drug | Ro11-2933 | 4.37e-05 | 2 | 151 | 2 | CID000115215 | |
| Drug | cnidiadin | 4.37e-05 | 2 | 151 | 2 | CID005315980 | |
| Drug | conferone | 4.37e-05 | 2 | 151 | 2 | CID001757335 | |
| Drug | oxyberberine | 4.37e-05 | 2 | 151 | 2 | CID000011066 | |
| Drug | VX-710-3 | 4.37e-05 | 2 | 151 | 2 | CID006450549 | |
| Drug | NAc-LLY-amide | 4.37e-05 | 2 | 151 | 2 | CID000443109 | |
| Drug | 62820-12-6 | 4.37e-05 | 2 | 151 | 2 | CID006449905 | |
| Drug | edatrexate | 4.45e-05 | 30 | 151 | 4 | CID000054586 | |
| Drug | AC1L9E0Q | 4.45e-05 | 30 | 151 | 4 | CID000443095 | |
| Drug | salbutamol | 5.51e-05 | 146 | 151 | 7 | CID000002083 | |
| Drug | 17beta-estradiol glucuronide | 5.79e-05 | 32 | 151 | 4 | CID000066424 | |
| Drug | NSC93767 | 5.79e-05 | 32 | 151 | 4 | CID000005658 | |
| Drug | magnesium | KRAS GPLD1 CPAMD8 ABCB5 PSMA6 LAMA1 LAMB2 CCT4 ADGRV1 PFKL GTPBP10 RYR3 ABCB1 BPNT1 TRNT1 RAB4B HRAS PKLR ALDH2 HSD17B8 OPLAH PMM1 | 6.41e-05 | 1325 | 151 | 22 | CID000000888 |
| Drug | beryllium fluoride | 6.49e-05 | 103 | 151 | 6 | CID000024589 | |
| Drug | trimetrexate | 6.55e-05 | 33 | 151 | 4 | CID000005582 | |
| Drug | saxitoxin | 7.20e-05 | 65 | 151 | 5 | CID000037165 | |
| Drug | AC1L8YYB | 7.38e-05 | 34 | 151 | 4 | CID000435167 | |
| Drug | Topo | 7.41e-05 | 153 | 151 | 7 | CID000065577 | |
| Drug | mexiletine | 7.75e-05 | 66 | 151 | 5 | CID000004178 | |
| Drug | disopyramide | 7.75e-05 | 66 | 151 | 5 | CID000003114 | |
| Drug | resiniferatoxin | 7.75e-05 | 66 | 151 | 5 | CID000104826 | |
| Drug | hepta-3 | 7.79e-05 | 13 | 151 | 3 | CID000150893 | |
| Drug | harmol sulfate | 7.79e-05 | 13 | 151 | 3 | CID005488302 | |
| Drug | thioinosine | 8.29e-05 | 35 | 151 | 4 | CID000676166 | |
| Drug | dibucaine | 8.94e-05 | 68 | 151 | 5 | CID000003025 | |
| Drug | Ursodeoxycholic Acid | 9.78e-05 | 276 | 151 | 9 | ctd:D014580 | |
| Drug | AC1LCF1F | 1.02e-04 | 161 | 151 | 7 | CID000627275 | |
| Drug | polyribosylribitol phosphate | 1.03e-04 | 112 | 151 | 6 | CID000002219 | |
| Drug | benzbromarone | 1.04e-04 | 37 | 151 | 4 | CID000002333 | |
| Drug | guanine | KRAS GPLD1 NRAS GNE PSMA6 GART ARHGEF12 XRCC1 GTPBP10 ARFRP1 THRB ARHGEF10 MTIF2 HRAS HERC1 IQGAP3 GAA | 1.05e-04 | 902 | 151 | 17 | CID000000764 |
| Drug | lipofectin | 1.09e-04 | 113 | 151 | 6 | CID006437083 | |
| Disease | generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology) | 1.48e-17 | 10 | 148 | 8 | DOID:0111294 (implicated_via_orthology) | |
| Disease | Dravet syndrome (implicated_via_orthology) | 1.48e-17 | 10 | 148 | 8 | DOID:0080422 (implicated_via_orthology) | |
| Disease | generalized epilepsy with febrile seizures plus (implicated_via_orthology) | 1.61e-16 | 12 | 148 | 8 | DOID:0060170 (implicated_via_orthology) | |
| Disease | Follicular thyroid carcinoma | 3.03e-09 | 5 | 148 | 4 | C0206682 | |
| Disease | Colorectal Neoplasms | KRAS ABCC3 CPAMD8 ABCC4 NRAS ABCB5 LAMA1 ABCB1 POSTN ABCB10 ALDH2 EP300 | 1.74e-08 | 277 | 148 | 12 | C0009404 |
| Disease | Generalized Epilepsy with Febrile Seizures Plus | 7.51e-08 | 9 | 148 | 4 | C3502809 | |
| Disease | Verrucous epidermal nevus | 1.24e-07 | 3 | 148 | 3 | C0362030 | |
| Disease | Nevus Sebaceus of Jadassohn | 1.24e-07 | 3 | 148 | 3 | C4552097 | |
| Disease | Organoid Nevus Phakomatosis | 1.24e-07 | 3 | 148 | 3 | C0265329 | |
| Disease | Linear nevus sebaceous syndrome | 1.24e-07 | 3 | 148 | 3 | cv:C4552097 | |
| Disease | Nevus sebaceous | 1.24e-07 | 3 | 148 | 3 | C3854181 | |
| Disease | Inflammatory linear verrucous epidermal nevus | 1.24e-07 | 3 | 148 | 3 | C0473574 | |
| Disease | SCHIMMELPENNING-FEUERSTEIN-MIMS SYNDROME | 1.24e-07 | 3 | 148 | 3 | 163200 | |
| Disease | linear nevus sebaceous syndrome (is_implicated_in) | 1.24e-07 | 3 | 148 | 3 | DOID:0111530 (is_implicated_in) | |
| Disease | Noonan syndrome 3 (implicated_via_orthology) | 1.24e-07 | 3 | 148 | 3 | DOID:0060581 (implicated_via_orthology) | |
| Disease | Linear Verrucous Epidermal Nevus | 1.24e-07 | 3 | 148 | 3 | C3179502 | |
| Disease | cervical cancer (implicated_via_orthology) | 1.24e-07 | 3 | 148 | 3 | DOID:4362 (implicated_via_orthology) | |
| Disease | epilepsy (implicated_via_orthology) | 1.46e-07 | 163 | 148 | 9 | DOID:1826 (implicated_via_orthology) | |
| Disease | Colorectal Carcinoma | KRAS ABCC3 CPAMD8 ABCC4 NRAS ABCB5 LAMA1 XRCC1 DSCAML1 ABCB1 POSTN ABCB10 B4GALNT2 ALDH2 DMD EP300 | 5.29e-07 | 702 | 148 | 16 | C0009402 |
| Disease | NEVUS, EPIDERMAL (disorder) | 1.23e-06 | 5 | 148 | 3 | C0334082 | |
| Disease | Febrile seizure (within the age range of 3 months to 6 years) | 1.76e-06 | 18 | 148 | 4 | HP_0002373 | |
| Disease | leukemia (implicated_via_orthology) | 2.22e-06 | 19 | 148 | 4 | DOID:1240 (implicated_via_orthology) | |
| Disease | Hemimegalencephaly | 2.45e-06 | 6 | 148 | 3 | C0431391 | |
| Disease | seminoma (is_implicated_in) | 2.45e-06 | 6 | 148 | 3 | DOID:4440 (is_implicated_in) | |
| Disease | Neuroblastoma | 3.84e-06 | 47 | 148 | 5 | C0027819 | |
| Disease | anxiety disorder (implicated_via_orthology) | 4.14e-06 | 22 | 148 | 4 | DOID:2030 (implicated_via_orthology) | |
| Disease | Seizure, Febrile, Simple | 4.26e-06 | 7 | 148 | 3 | C0149886 | |
| Disease | Seizure, Febrile, Complex | 4.26e-06 | 7 | 148 | 3 | C0751057 | |
| Disease | Ventricular Dysfunction | 6.80e-06 | 8 | 148 | 3 | C0242973 | |
| Disease | Neurodevelopmental Disorders | 7.66e-06 | 93 | 148 | 6 | C1535926 | |
| Disease | Febrile Convulsions | 1.02e-05 | 9 | 148 | 3 | C0009952 | |
| Disease | cystic fibrosis (implicated_via_orthology) | 1.02e-05 | 9 | 148 | 3 | DOID:1485 (implicated_via_orthology) | |
| Disease | RASopathy (implicated_via_orthology) | 1.02e-05 | 9 | 148 | 3 | DOID:0080690 (implicated_via_orthology) | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 1.22e-05 | 152 | 148 | 7 | DOID:0060041 (implicated_via_orthology) | |
| Disease | Epilepsy | 1.90e-05 | 109 | 148 | 6 | C0014544 | |
| Disease | Noonan Syndrome 1 | 1.98e-05 | 11 | 148 | 3 | C4551602 | |
| Disease | Turner Syndrome, Male | 1.98e-05 | 11 | 148 | 3 | C0041409 | |
| Disease | Female Pseudo-Turner Syndrome | 1.98e-05 | 11 | 148 | 3 | C1527404 | |
| Disease | kidney cancer (implicated_via_orthology) | 1.98e-05 | 11 | 148 | 3 | DOID:263 (implicated_via_orthology) | |
| Disease | RAS-ASSOCIATED AUTOIMMUNE LEUKOPROLIFERATIVE DISORDER | 2.50e-05 | 2 | 148 | 2 | 614470 | |
| Disease | Usher syndrome, type 2C | 2.50e-05 | 2 | 148 | 2 | C2931213 | |
| Disease | Autoimmune lymphoproliferative syndrome type 4 | 2.50e-05 | 2 | 148 | 2 | cv:C2674723 | |
| Disease | autoimmune lymphoproliferative syndrome type 4 (is_implicated_in) | 2.50e-05 | 2 | 148 | 2 | DOID:0110117 (is_implicated_in) | |
| Disease | USHER SYNDROME, TYPE IIC | 2.50e-05 | 2 | 148 | 2 | 605472 | |
| Disease | MELANOCYTIC NEVUS SYNDROME, CONGENITAL | 2.50e-05 | 2 | 148 | 2 | 137550 | |
| Disease | Early Infantile Epileptic Encephalopathy 6 | 2.50e-05 | 2 | 148 | 2 | C4551549 | |
| Disease | Melanocytic nevus | 2.50e-05 | 2 | 148 | 2 | cv:C0027962 | |
| Disease | RAS-ASSOCIATED AUTOIMMUNE LEUKOPROLIFERATIVE DISORDER | 2.50e-05 | 2 | 148 | 2 | C2674723 | |
| Disease | Usher syndrome type 2C | 2.50e-05 | 2 | 148 | 2 | cv:C2931213 | |
| Disease | large congenital melanocytic nevus (is_implicated_in) | 2.50e-05 | 2 | 148 | 2 | DOID:0111359 (is_implicated_in) | |
| Disease | Usher syndrome type 2C (is_implicated_in) | 2.50e-05 | 2 | 148 | 2 | DOID:0110839 (is_implicated_in) | |
| Disease | Large congenital melanocytic nevus | 2.50e-05 | 2 | 148 | 2 | cv:C1842036 | |
| Disease | Infantile Severe Myoclonic Epilepsy | 3.41e-05 | 13 | 148 | 3 | C0751122 | |
| Disease | hepatocellular carcinoma (is_implicated_in) | 3.76e-05 | 181 | 148 | 7 | DOID:684 (is_implicated_in) | |
| Disease | T wave morphology measurement | 4.32e-05 | 14 | 148 | 3 | EFO_0008398 | |
| Disease | Cardiomyopathies | 5.14e-05 | 130 | 148 | 6 | C0878544 | |
| Disease | Neoplasm of uncertain or unknown behavior of breast | 5.33e-05 | 41 | 148 | 4 | C0496956 | |
| Disease | Breast adenocarcinoma | 5.33e-05 | 41 | 148 | 4 | C0858252 | |
| Disease | MMR-related febrile seizures | 5.38e-05 | 15 | 148 | 3 | EFO_0006519 | |
| Disease | RASopathy | 5.38e-05 | 15 | 148 | 3 | cv:C5555857 | |
| Disease | Epilepsy, Cryptogenic | 5.93e-05 | 82 | 148 | 5 | C0086237 | |
| Disease | Awakening Epilepsy | 5.93e-05 | 82 | 148 | 5 | C0751111 | |
| Disease | Aura | 5.93e-05 | 82 | 148 | 5 | C0236018 | |
| Disease | high grade glioma (implicated_via_orthology) | 7.06e-05 | 44 | 148 | 4 | DOID:3070 (implicated_via_orthology) | |
| Disease | B Virus Infection | 7.47e-05 | 3 | 148 | 2 | C0037140 | |
| Disease | Benign familial infantile epilepsy | 7.47e-05 | 3 | 148 | 2 | cv:C5575231 | |
| Disease | Postherpetic neuralgia | 7.47e-05 | 3 | 148 | 2 | C0032768 | |
| Disease | Herpesviridae Infections | 7.47e-05 | 3 | 148 | 2 | C0019372 | |
| Disease | Primary Erythermalgia | 7.47e-05 | 3 | 148 | 2 | C0014805 | |
| Disease | GIANT PIGMENTED HAIRY NEVUS | 7.47e-05 | 3 | 148 | 2 | C1842036 | |
| Disease | PAROXYSMAL EXTREME PAIN DISORDER | 7.47e-05 | 3 | 148 | 2 | C1833661 | |
| Disease | Noonan-Like Syndrome With Loose Anagen Hair | 1.13e-04 | 19 | 148 | 3 | C3501846 | |
| Disease | Noonan syndrome-like disorder with loose anagen hair | 1.13e-04 | 19 | 148 | 3 | C1843181 | |
| Disease | Cardio-facio-cutaneous syndrome | 1.13e-04 | 19 | 148 | 3 | C1275081 | |
| Disease | Costello syndrome (disorder) | 1.13e-04 | 19 | 148 | 3 | C0587248 | |
| Disease | Paroxysmal atrial fibrillation | 1.41e-04 | 156 | 148 | 6 | C0235480 | |
| Disease | familial atrial fibrillation | 1.41e-04 | 156 | 148 | 6 | C3468561 | |
| Disease | Persistent atrial fibrillation | 1.41e-04 | 156 | 148 | 6 | C2585653 | |
| Disease | Brugada ECG Pattern | 1.49e-04 | 4 | 148 | 2 | C1721096 | |
| Disease | NEVUS, EPIDERMAL | 1.49e-04 | 4 | 148 | 2 | 162900 | |
| Disease | Malignant neoplasm of penis | 1.49e-04 | 4 | 148 | 2 | C0153601 | |
| Disease | Penile Neoplasms | 1.49e-04 | 4 | 148 | 2 | C0030849 | |
| Disease | Nevus, Keratinocytic, Nonepidermolytic | 1.49e-04 | 4 | 148 | 2 | C4011754 | |
| Disease | BLADDER CANCER | 1.49e-04 | 4 | 148 | 2 | 109800 | |
| Disease | Epidermal nevus | 1.49e-04 | 4 | 148 | 2 | cv:C0334082 | |
| Disease | Malignant tumor of urinary bladder | 1.49e-04 | 4 | 148 | 2 | cv:C0005684 | |
| Disease | Thyroid cancer, nonmedullary, 2 | 1.49e-04 | 4 | 148 | 2 | cv:C4225426 | |
| Disease | Malignant tumor of cervix | 1.49e-04 | 4 | 148 | 2 | C0007847 | |
| Disease | epidermal nevus (is_implicated_in) | 1.49e-04 | 4 | 148 | 2 | DOID:0111162 (is_implicated_in) | |
| Disease | THYROID CANCER, NONMEDULLARY, 2 | 1.49e-04 | 4 | 148 | 2 | 188470 | |
| Disease | chronic myeloid leukemia (is_implicated_in) | 1.54e-04 | 21 | 148 | 3 | DOID:8552 (is_implicated_in) | |
| Disease | Atrial Fibrillation | 1.62e-04 | 160 | 148 | 6 | C0004238 | |
| Disease | acute lymphoblastic leukemia (is_implicated_in) | 1.70e-04 | 55 | 148 | 4 | DOID:9952 (is_implicated_in) | |
| Disease | LEOPARD Syndrome | 1.78e-04 | 22 | 148 | 3 | C0175704 | |
| Disease | Noonan Syndrome | 2.32e-04 | 24 | 148 | 3 | C0028326 | |
| Disease | THYROID CANCER, NONMEDULLARY, 2 | 2.47e-04 | 5 | 148 | 2 | C4225426 | |
| Disease | Malignant neoplasm of thyroid | 2.47e-04 | 5 | 148 | 2 | C0007115 | |
| Disease | Cetuximab response | 2.47e-04 | 5 | 148 | 2 | cv:CN077967 | |
| Disease | Duchenne and Becker Muscular Dystrophy | 2.47e-04 | 5 | 148 | 2 | C3542021 | |
| Disease | Cervix carcinoma | 2.47e-04 | 5 | 148 | 2 | C0302592 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GQQSGLKILGQLTTD | 421 | Q6PI77 | |
| GASGLGLQIQTKTVL | 266 | Q09472 | |
| GTVQGQLQGPISKVR | 46 | P07311 | |
| NVIGQITQLIGNLKG | 761 | O15013 | |
| RGIIGGKSQRVNGLT | 2281 | Q9NR48 | |
| VVQGRGQKQLIISTS | 246 | Q8NHY0 | |
| QVSGLQLLASVGKTG | 201 | Q6L9W6 | |
| GLNGSGKSTVVQLLQ | 421 | Q2M3G0 | |
| LNQLLKGVTIASGGV | 91 | Q9P0M6 | |
| LNQLLKGVTIASGGV | 91 | O75367 | |
| VILLNGTGGAKVGNR | 976 | Q8WXG9 | |
| KATIQGVLRAGSQLR | 556 | O95782 | |
| FVGAGIIQTKALQVG | 926 | O95782 | |
| GVLLSGGQKQRIAIA | 631 | Q9NRK6 | |
| ARAIAVQKGSIGNLI | 2216 | Q8NFD5 | |
| VGNILQLGSKLIGTG | 396 | P11532 | |
| GDRVVIAGQKVGTLR | 286 | Q8N3C7 | |
| LRVGGAGNKIIQLIE | 216 | O95861 | |
| AGVQTGDRIIKVNGT | 106 | Q9NZN5 | |
| GISKVGIRKLINNGS | 321 | Q9BYT9 | |
| VKVQGGGGSLVITQI | 381 | Q8TDY8 | |
| AGGVGKSALTIQLIQ | 11 | P01112 | |
| AGGVGKSALTIQLIQ | 11 | P01116 | |
| AGGVGKSALTIQLIQ | 11 | P01111 | |
| GSRVVNVGGKTVKLQ | 46 | P61018 | |
| EKGINLSGGQRQRVS | 746 | O15438 | |
| KGAIGSRLAVITQNI | 826 | P08183 | |
| VLKRGLQQITGHGGL | 6 | Q9UI09 | |
| QALIVGVKKGGTRAV | 116 | Q9Y278 | |
| GSNKRIGQVVNTGVL | 271 | A9QM74 | |
| VFNGKRVLVVGLGNS | 181 | P31513 | |
| TSQVLGLGINGKVLQ | 66 | P49137 | |
| GQLNIGISNIKAIGV | 76 | Q14409 | |
| KGRGLVTTAIIQRGT | 366 | P46199 | |
| IQRGTLRKGSVLVAG | 376 | P46199 | |
| QILGGGQVATLSKLL | 651 | Q9C0I1 | |
| LVRTRGGNTGVVKVQ | 1281 | Q5HYC2 | |
| LVTGLQGKNVRQISA | 4336 | Q15751 | |
| KIQLQGGITSITLRG | 286 | Q8N1V2 | |
| KGQIQEIVLVGGSTR | 331 | P54652 | |
| GTVGGRLATISVNKQ | 61 | Q8NBM8 | |
| GIKVGDQVLAANGVR | 251 | Q9H5P4 | |
| QRGDRLIAIGGVKIT | 411 | Q8NEN9 | |
| IIQLGGTIIGSARCK | 76 | P17858 | |
| SGIKGLQGVVRKTVN | 166 | Q9Y2G0 | |
| GLGNQVEVLKTRGIN | 1261 | Q9P265 | |
| VTLGGVLRQQLVVSK | 301 | Q9P2J3 | |
| EKLGIVQGIVGARNT | 1236 | P55268 | |
| LVTQVENGGVLGSRK | 236 | P30613 | |
| CILIRGVGKSVLVGN | 181 | Q8TCJ0 | |
| GGLRQVLQGLLSSKV | 1411 | Q9UMN6 | |
| GEGVTLQGNITLLKG | 41 | Q9GIP4 | |
| QSSSTLKGVLVRNGG | 96 | P28290 | |
| VVALRGGLNTILKNV | 201 | Q6R327 | |
| GRGQSALQEILGKVI | 1046 | Q86VI3 | |
| RSIGNKNTILLGLGF | 306 | Q96MC6 | |
| VIVTGANTGIGKQTA | 41 | Q8NBN7 | |
| QALRQLQTLKGGLGV | 1781 | Q7Z442 | |
| IGAGSKTLGARQRLQ | 811 | A6NF01 | |
| KIGITLSNAIVNAGL | 936 | A2PYH4 | |
| RGTTLSGGQKARVNL | 531 | O15439 | |
| KRLTINGGSNGGLLV | 546 | P48147 | |
| VASKGRGGLLEVNLQ | 66 | Q9UN74 | |
| VSQGIVGIRGVFSNK | 126 | P12034 | |
| FQRKTLVLIGAQGVG | 336 | Q9NZW5 | |
| RAKAGVQSGTNALLV | 336 | Q8N7H5 | |
| SKRLQGQLQGGSREI | 186 | Q9UP83 | |
| TVGLNIGTVDVGKAR | 56 | Q13795 | |
| TRVIEFTTVGIGGKN | 3981 | Q4G0P3 | |
| ILVAQGGLGGKLLTN | 116 | A4D1E9 | |
| GTVLNNKLFITGGIT | 421 | Q96M94 | |
| LVNKGILVQTRGTGA | 91 | P22492 | |
| VKLNCRILGVGISTG | 461 | Q9Y223 | |
| KQFIRSVGEGTINGL | 11 | Q5XLA6 | |
| RKDGQVIISGSGVTI | 631 | Q8TD84 | |
| LTQKGSGNAVVIVVG | 171 | Q6ZPD8 | |
| IINISSIVGKVGNVG | 151 | Q92506 | |
| RNVVQTGKAVGQSVG | 601 | Q8NBF6 | |
| LAVGRVLNKDIQGGI | 1251 | Q8IZJ3 | |
| QGGSIVNVGSIVGLK | 126 | Q8N4T8 | |
| GKQGVRGAVSTLLQA | 511 | P00519 | |
| GAGLQLQKVTVLGVA | 896 | P10253 | |
| ILKNLTTTGRQFGGI | 361 | Q5I0G3 | |
| GAAAVVLGKQVLVVG | 71 | Q8IXV7 | |
| GLSKGIVQGVLATIN | 236 | Q8IW92 | |
| SVNGEVLTGAIKRGV | 1906 | Q8NDH2 | |
| AVARALVQQGLKVVG | 26 | Q6UWP2 | |
| AVIGRGGSKIKNIQS | 81 | Q9NXZ2 | |
| GGGSGIVQNTKALIL | 2531 | Q02224 | |
| VGVLGSKLGLQVVEL | 51 | O94760 | |
| KGVVTAGQVRGNSTV | 511 | Q5VU65 | |
| AGSIIGKGGQTIVQL | 61 | P51513 | |
| TVVFQGAAGIGKTIL | 221 | Q96P20 | |
| VGLIIGRGGEQINKI | 156 | Q92945 | |
| GFIIKTGLGNQSTRV | 1711 | P0C091 | |
| LVGAVNVAKGTVQTG | 591 | Q96Q06 | |
| TGLTGAVNLAKGTVQ | 886 | Q96Q06 | |
| LNGSQIGLLRKAGIQ | 131 | Q8N2A8 | |
| ATQAVLLGIGVGNAK | 111 | Q96GQ5 | |
| TNQTKGLLRAAAVGI | 431 | Q9Y5W8 | |
| VGISSGKEIGALLQQ | 396 | Q96Q11 | |
| KIIGNSVGALGNLTL | 691 | P35499 | |
| VNGLTLGGQKCSVIR | 61 | P07737 | |
| SILAVGVGNVRVKFG | 786 | Q8N3T6 | |
| ALQGKLGGVQRVLST | 166 | Q6T4R5 | |
| RKNGRTVNLGGKTSV | 1221 | O14841 | |
| IIKGNGLTLSTQAEG | 611 | P25391 | |
| QRGQTVGSVGKVGQV | 361 | Q8TDN2 | |
| LIGQGIIVKDARLNG | 51 | Q8NEK8 | |
| GTKILQSIQRGIQVT | 176 | Q8TEB7 | |
| NTLIKIIGNSVGALG | 826 | Q14524 | |
| IKIIGNSVGALGNLT | 856 | Q15858 | |
| GGLQVLRTLVQEKGT | 311 | Q9H173 | |
| IIVGNGGVLANKSLG | 161 | Q11203 | |
| GILVSLSTGGRKQNL | 536 | Q8N695 | |
| AGINVRKGGISNILE | 491 | P50991 | |
| IITLTVGTNGGLKVV | 1656 | Q9NT68 | |
| VGTNGGLKVVSTQNL | 1661 | Q9NT68 | |
| LIKIIGNSVGALGNL | 871 | Q9NY46 | |
| SQAKVQRILRLISGG | 196 | Q8NHU3 | |
| KLRSRVQIGVVGGSD | 41 | Q92871 | |
| GQVLKNFSGRIEGIQ | 11 | Q9BWV2 | |
| KIIGNSVGALGNLTL | 881 | P35498 | |
| GGLQRSLKIRIQVAG | 106 | Q9HCU9 | |
| GKVIILTAAAQGIGQ | 6 | Q9BUT1 | |
| IGRVIQVAAGSSNLK | 266 | P05091 | |
| ATAGIIGVNRKGQVL | 311 | Q00610 | |
| AINQGGLTSVAVRGK | 31 | P60900 | |
| KVVGDLLSGTILVGQ | 1091 | Q63HN8 | |
| LTNKIGTVLGFNVGR | 1721 | Q8IZQ1 | |
| QGGVAQLVIKGARDS | 96 | Q8WVN6 | |
| IGGTLQGFISDVLQK | 341 | Q8NCC5 | |
| AAVTIGFGQIKNLLG | 161 | Q86WA9 | |
| VETLKLGIAILNGGN | 3646 | Q15413 | |
| LIKIIGNSVGALGNL | 776 | Q9Y5Y9 | |
| VVGQSGLGKSTLVNT | 66 | Q9UH03 | |
| IRGGLSNLGIKSIVT | 126 | Q86SZ2 | |
| VTRGQLKNGGLGVVS | 336 | P10828 | |
| TAKGGVGKLVTLRNV | 236 | Q8IX01 | |
| GALKGDGILIVVNTV | 61 | Q9BRV3 | |
| IKIIGNSVGALGNLT | 871 | Q99250 | |
| VKSGISFLIQTGVGI | 46 | Q9GZP7 | |
| AKNQVVIAAGRSSLG | 811 | P80108 | |
| EKITQRGGLSNVGRA | 361 | Q6UXI7 | |
| VETIGLLQSTSGKQG | 511 | Q9Y2X9 | |
| KIIGNSVGALGNLTL | 866 | Q9UQD0 | |
| NGKVVTHGGRVLAVT | 376 | P22102 | |
| LIKGVERLISGQQGL | 926 | Q9H2K2 | |
| NKVAVLLLAGGQGTR | 101 | Q16222 | |
| GQLQVGLGISNLSKS | 116 | Q96MT0 | |
| GRTASLIIKVQQLNG | 2706 | Q7Z7G8 | |
| LGKILQGVVVVLSGF | 316 | P18887 | |
| GKQITGVSILRAGET | 391 | Q9NWZ5 | |
| VSVQLGDGTRLKGTV | 386 | Q8N1G0 | |
| GQILETIGGKQLRVF | 446 | Q15063 | |
| INGQIAKDLGTLVAG | 651 | Q96PF1 | |
| VRVVKQEAGGLGISI | 116 | Q13425 | |
| LARVTKVLGRTGSQG | 11 | P62857 | |
| QLVLGAGALQVVGLK | 786 | Q9P1Q0 | |
| LKGRRTLVGGQQVTL | 1226 | Q9Y493 | |
| LDGGSGVRALKVIQQ | 3356 | Q5THJ4 |